Scientific publications
-
Sàbat, P, Ajenjo-Bauza, M, Hierro, C, Ruffinelli, JC, Gil-Martin, M, Ochoa-de-Olza, M, Bergamino, M, Calvo, M, Soto-Castillo, JJ, Fina, C, Llop, S, Stradella, A, Oliva, M, Notario, L, Carcereny, E, Teixidor-Vilà, E, Domènech, M, Jové, M, Villanueva, R, Alay, A, Azuara, D, González-Acosta, M, Otero-Torres, S, Gausachs, M, Varela, M, Villatoro, S, Solanes, A, Teulé, A, Cuadra, C, Moreno, V, Nadal, E, Cordero, D, Lázaro, C and Martin-Liberal, J.
Implementing a molecular prescreening strategy for tumors without public NGS access in a cancer center network: Results from the PREICO project
European Journal of Cancer 239:
-
Losa, F, Etxaniz, O, Giménez, A, Gomila, P, Iglesias, L, Longo, F, Nogales, E, Sánchez, A, Soler, G and Fernández, I.
SEOM-GECOD clinical guideline for cancer of unknown primary (update 2025)
CLINICAL & TRANSLATIONAL ONCOLOGY 28(5): 1610-1623
-
Yaringaño, J, Mirallas, O, Navarro, V, Gómez-Puerto, D, Velilla, G, Vaz, MA, Gorria, T, Martínez-Monino, A, Hernández, A, Aguado, M, Di Muzio, A, Valbuena, DL, Ruiz-Pace, F, González, M, Martínez-García, M, Villacampa, G, Balaña, C, Carles, J, Dienstmann, R, Pineda, E, Sepúlveda, JM and Vieito, M.
Progression-Free Survival 2 as a Potential Surrogate for Overall Survival in Glioblastoma: Insights From a Spanish Multicentric Cohort
Cancer Medicine 15(4):
-
Coma, MI, Badia-Ramentol, J, Martinez-Ciarpaglini, C, Linares, J, Tarazona, N, Mulet-Margalef, N, Tornero-Piñero, P, Sallent-Aragay, A, Recort-Bascuas, A, Gibert, J, Sant-Albors, M, Tauriello, DVF, Cruz-Moral, M, Carreras-Gallardo, M, Sancho, E, Martinez, CM, Garrido, M, Mozo, JLM, Cervantes, A, Montagut, C, Batlle, E and Calon, A.
Stromal biomarker-based framework for identifying pMMR/MSS and dMMR/MSI colorectal cancers with poor outcomes and limited benefit from immunotherapy
Gut :
-
Economopoulou, P, Pouliakis, A, Kyprianou, M, Pantazopoulos, A, Spathis, A, Kotsantis, I, Cavalieri, S, Oliva, M, Rogado, J, Pena, C, Iglesias, L, Baste, N, Castelo, B, Fountzilas, E, Martinez-Vila, C, Salamero, MC, Triaridis, S, Frutos, IDD, Unal, E, Ong, EHW, Chua, MLK, Papouliakos, S, Hamid, H, Saba, NF, Mesia, R, Licitra, L and Psyrri, A.
An observational retro-prospective study on patients with head and neck cancer who contracted COVID-19 (HERODOTUS: head and neck cancERs international cOviD-19 collabOraTion)
Oral Oncology 175:
-
Gregorc, V, Majem, M, Lo Russo, G, Maio, M, Salvagni, S, Gutiérrez-Calderon, V, Gonzalez-Cao, M, Contreras, SS, Koumarianou, A, Bearz, A, Bernabé-Caro, R, Viteri, S, de Sanmamed, MF, Zagouri, F, Bueno, TM, Lazzari, C, Martínez-Recio, S, Giménez-Capitán, A, Zhang, Y, Shan, Y, Zhu, HQ, Zhao, CQ, Shen, HG, Wang, Y and Rosell, R.
Fulzerasib plus cetuximab in first-line KRASG12C-mutated nonsmall-cell lung cancer (KROCUS): a single-arm, multicentre, phase 1b/2 trial
LANCET ONCOLOGY 27(4): 432-441
-
Domínguez, AR, Cirauqui, B, Castaño, AG, Cabellos, RA, Maseda, AC, Fernández, BC, Rey, LI, Rubió-Casadevall, J, Arrazubi, V and Mesía, R.
SEOM-TTCC clinical guideline for nasopharyngeal carcinoma (update 2025)
CLINICAL & TRANSLATIONAL ONCOLOGY 28(4): 1151-1164
-
Ezeonwumelu, IJ, Garcia-Vidal, E, Felip, E, de las Heras, S, Clotet, B, Badia, R, Ballana, E, Riveira-Muñoz, E and Nevot, M.
Modulation of IRF7-driven transcription as a strategy to control HIV-1 latency
Frontiers in Immunology 17:
-
Albors, MS, Jarroudi, RBE, Sánchez, SG, Blázquez-Albisu, A, Fernandez, SE, Rodríguez, SP, Martín, EC and Monzo, JLM.
Long Term of Follow-Up of Melanoma-Associated Retinopathy: A Case Report
Ocular Immunology and Inflammation 34(2): 260-264
-
Solé-Blanch, C, España, S, de la Puente-Noel, A, Marin-Béjar, O, Manzano, JL and Martinez-Cardús, A.
Same mutation, different fates: The Yin-Yang of BRAF-driven therapeutic responses in melanoma and colorectal cancer
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER 1881(1): 189503-189503
-
Gonzalez-Cao, M, Berciano-Guerrero, MA, Muñoz-Couselo, E, Manzano, JL, Cerezuela-Fuentes, P, Crespo, G, Soria, A, de Miguel, PA, Sanz, LG, de la Rosa, CA, Castaño, AG, Puértolas, T, Espinosa, E, Medina, J, Bellido, L, Berrocal, A, Majem, M, Castro, RL, Fernandez, LA, Garcia, F, de la Borbolla, MR, Algarra, SM and Márquez-Rodas, I.
Poor efficacy of anti PD-1 antibody based immunotherapy in patients with acral melanoma: results from the Spanish Melanoma Group (GEM) registry
CLINICAL & TRANSLATIONAL ONCOLOGY 28(2): 645-653
-
Bourhis J, Aupérin A, Borel C, Lefebvre G, Racadot S, Geoffrois L, Sun XS, Saada E, Cirauqui B, Rutkowski T, Henry S, Modesto A, Johnson A, Chapet S, Calderon B, Sire C, Malard O, Bainaud M, Da Silva Motta A, Thureau S, Pointreau Y, Blanchard P, Buiret G, Bozec L, Lopez S, Vanbockstael J, Bosset M, Greilsamer C, Daste A, Bruna A, N'Guyen F, Plana M, Iruarrizaga E, Temam S, Even C, Ruiz EP, Bert M, Karamouza E, Thariat J, Kazmierska J, Psyrri A, Mesia R and Tao Y.
Nivolumab added to cisplatin and radiotherapy versus cisplatin and radiotherapy alone after surgery for people with squamous cell carcinoma of the head and neck at a high risk of relapse (GORTEC 2018-01 NIVOPOST-OP): a randomised, open-label, phase 3 trial.
LANCET 407(10526): 363-374
-
Borrego, MR, Lopez-Bravo, DP, Vila, MM, Pérez-García, JM, Fernández, M, Tormo, SB, García-Saenz, JA, Lema, L, Garau, I, Cortez, P, Torres, AA, Conejo, EA, Calvo, I, Ferrer, N, Blancas, I, Amillano, K, Santasusagna, S, Benderra, MA, Alcalá-Lopez, D, Antonarelli, G, Sampayo-Cordero, M, Llombart-Cussac, A and Cortés, J.
Liposomal irinotecan in patients with HER2-negative breast cancer and brain metastases: The PHENOMENAL phase 2 study
European Journal of Cancer 233: 116161-116161
-
Carcereny, E, Lopez, A, Coma, M, Ponce, C, Buxó, L and Martinez-Cardús, A.
A Systems Biology and Artificial Intelligence Approach to Unveil Brigatinib's Pharmacological Mechanism in Brain Metastases in ALK plus Non-Small Cell Lung Cancer
Biomedinformatics 6(1):
-
Mirallas, O, Ruiz-Pace, F, Velilla, G, Gómez-Puerto, D, Gorria, T, Yaringaño, J, Martínez-Monino, A, López-Valbuena, D, Vaz, MA, Hernandez, A, Martínez-Saez, E, Sorolla, MA, Castro-Henriques, M, Bardaji, JL, Di Muzio, A, Gallego, O, Martínez-García, M, Domenech, M, Carles, J, Balaña, C, Pineda, E, Dienstmann, R, Vieito, M and Sepúlveda, JM.
Clinical actionability in gliomas revealed by real-world next-generation sequencing: a multicentric study
Npj Precision Oncology 10(1):
-
Mattavelli, D, Compagnoni, M, Calza, S, Ravanelli, M, Plana, M, Wichmann, G, Paderno, A, Zhan, Y, Smussi, D, Rondi, P, Pinacoli, A, Medda, A, Lorini, L, Khelik, K, Hovig, E, Maffini, FA, Kalogerini, M, Alberti, A, Farina, D, Dietz, A, Mesia, R, Piazza, C, Chiocca, S and Bossi, P.
A multiomic framework for predicting laryngo-esophageal dysfunction following induction chemotherapy in hypopharyngeal-laryngeal carcinoma
ESMO Open 11(1): 105933-105933
-
Garcia-Saenz, JA, Lopez-Barajas, IB, Echavarria, I, Gonzalez, CH, Vila, MM, Antón, FM, Pernas, S, Cajal, TRY, Ribelles, N and Ezquerra, MB.
SEOM-GEICAM-SOLTI clinical guidelines in advanced breast cancer (UPDATE 2025)
CLINICAL & TRANSLATIONAL ONCOLOGY 28(1): 126-147
-
Calle, C, Elez, E, Manzano, JL, Moreno-Martinez, ME, Pericay, C, Graefenhain, R, Ariznavarreta, A and Lizan, L.
Value contribution of trifluridine/tipiracil with bevacizumab for the treatment of metastatic colorectal cancer in Catalonia using a multicriteria decision analysis
Journal of Pharmaceutical Policy and Practice 18(1): 2567970-2567970
-
Queralt, C, Moreta-Moraleda, C, Costa, M, Grau-Leal, F, Diesch, J, Vendrell-Ayats, C, Musulén, E, Wright, RHG, Bugés, C, Manzano, JL, de las Heras, SC, Zuber, J, Buschbeck, M, Forcales, S and Martínez-Balibrea, E.
Loss-of-function genetic screen unveils synergistic efficacy of PARG inhibition with combined 5-fluorouracil and irinotecan treatment in colorectal cancer
Clinical and Translational Medicine 15(12):
-
Cerezuela-Fuentes, P, Piñero-Madrona, A, Muñoz-Couselo, E, Manzano, JL, Berciano-Guerrero, MA, Majem, M, Espinosa, E, Soria, A, de Miguel, PA, Castaño, AG, Crespo, G, Sanz, LG, de la Rosa, CA, Fernández-Morales, LA, Puértolas, T, Rodríguez, JF, de la Borbolla, MR, Bellido, L, Castro, RL, Pérez, VN, Arroyo, FRG, Guzmán, JCV, Balea, BC, Hernández, B, Algarra, SM and Márquez-Rodas, I.
Title: Characterization of Melanoma of Unknown Primary in the Era of Immunotherapy and Targeted Therapy in Spain: Results from the Prospective Real World Study GEM 1801
CLINICAL & TRANSLATIONAL ONCOLOGY :
-
Capdevila, J, Tafuto, S, Krogh, M, Teulé, A, Garcia-Carbonero, R, Klümpen, HJ, Cremer, B, Sevilla, I, Eriksson, B, Tabaksblat, E, Metges, JP, Reed, NS, Schrader, J, Navarro, V, Valentí, V, Hernando, J, Colao, AM, Vestermark, L, Carnaghi, C, Knigge, UP, Jimenez-Fonseca, P, Benavent, M, de Vos-Geelen, J, Venerito, M, Von Werder, A, Jann, H, Rinke, A, Smith, D, Hörsch, D, Starling, N, Ruszniewski, P, Baudin, E, Caroli-Bosc, FX, Manzano, JL, Martín, M, Scarpa, A, Lawlor, RT, Ragulan, C, Ps, H, Sadanandam, A, Carmona-Bayonas, A and Salazar, R.
Streptozotocin plus 5-fluorouracil followed by everolimus or the reverse sequence in patients with advanced pancreatic neuroendocrine tumors (SEQTOR-GETNE phase III study): a randomized clinical trial
ESMO Open 10(12): 105922-105922
-
Cerezuela-Fuentes, P, de la Rosa, CA, Crespo, G, Berciano-Guerrero, MA, Soria, A, Muñoz-Couselo, E, Castro, RL, Majem, M, de Miguel, PA, Manzano, JL, Bellido, L, Lecumberri, MJ, Subias, MC, Guzmán, JCV, Hernández, B, Espinosa, E, Puértolas, T, Sanz, LG, Martínez, JM, Abril, VP, Algarra, SM and Márquez-Rodas, I.
Treatment outcomes in patients with advanced mucosal melanoma in Spain: results from the real-world GEM1801 study
Melanoma Research 35(6): 399-408
-
Espinosa, E, Berciano-Guerrero, MA, Muñoz-Couselo, E, Puértolas, T, Manzano, JL, Soria, A, De Miguel, PA, Crespo, G, Sanz, LG, Cerezuela-Fuentes, P, de la Rosa, CA, Majem, M, Castaño, AG, Berrocal, A, Arroyo, FRG, de la Borbolla, MR, Bellido, L, Martínez, JM, Fernández, LA, Carnicero, AM, Castro, RL, Rodríguez, AB, Lecumberri, MJ, Guzmán, JCV, Balea, BC, Rodríguez, JF, Bautista, JV, Pérez, VN, Mujika, K, Subias, MC, Hernández, B, Algarra, SM and Márquez-Rodas, I.
Response rate and long-term survival in patients with advanced melanoma: data from the prospective cohort study gem-1801
CLINICAL & TRANSLATIONAL ONCOLOGY :
-
Navarro-Jiménez, M, González, B, Mulet, N, Hierro, C and Alonso, S.
KRAS-targeted therapies in colorectal cancer: a systematic analysis of mutations, inhibitors, and clinical trials
Npj Precision Oncology 9(1): 380-380
-
de Porras, VR, Bakht, MK, Fernandez-Saorín, M, Alcon, C, Palomero, L, Francisco-Rodon, J, Figols, M, Montero, J, Conteduca, V, Beltran, H and Font, A.
YM155 Inhibition of Survivin Enhances Carboplatin Efficacy in Metastatic Castration-Resistant Prostate Cancer
Pharmaceuticals 18(11):
-
Alberti, A, Gurizzan, C, Resteghini, C, Trama, A, Bernasconi, A, Grisanti, S, Zamparini, M, Mohamad, I, Galiana, IL, Ozyar, E, Franco, P, Vecchio, S, Bonomo, P, Cirauqui, B, El-Sherify, M, Ursino, S, Argiris, A, Pan, J, Wittekindt, C, D'Angelo, E, Costa, L, Buglione, M, Johnson, JM, Airoldi, M, Mesia, R, Licitra, L, Orlandi, E and Bossi, P.
A multicenter retrospective analysis of recurrent/metastatic nasopharyngeal cancer from non-endemic areas: Results in the pre-immunotherapy era
European Journal of Cancer 229: 115749-115749
-
Machiels, JP, Tao, Y, Licitra, L, Burtness, B, Tahara, M, Rischin, D, Alves, GV, Lima, IPF, Hughes, BGM, Pointreau, Y, Aksoy, S, Laban, S, Greil, R, Burian, M, Hetnal, M, Delord, JP, Mesia, R, Taberna, M, Waldron, J, Simon, C, Gregoire, V, Harrington, K, Black, CM, Norquist, JM, Wang, A, Gumuscu, B, Bidadi, B and Siu, LL.
Health-related quality of life outcomes from KEYNOTE-412: chemoradiotherapy with or without pembrolizumab in participants with head and neck squamous cell carcinoma
Frontiers in Oncology 15: 1645509-1645509
-
Bossi, P, Kiyota, N, Mesia, R, Rosenberg, AJ, Martino, R, Posorske, CF, Salmio, S, Schroeder, A and Yom, SS.
Adverse event profiles and management of cisplatin-based chemoradiotherapy in locally advanced head and neck squamous cell carcinoma: a systematic review
Oral Oncology 169: 107596-107596
-
Arribas, L, Hurtós, L, Esteve, A, Peiró, I, González-Tampán, AR, Choulli, M, Antonio, M, Vilajosana, E, Borbalas, AL, Taberna, M and Mesia, R.
Nutritional impact of eicosapentaenoic acid supplementation (EPA) in patients with locally advanced head and neck cancer: a double-blind placebo-controlled randomized trial
Nutrition Journal 24(1): 140-140
-
Martelli, V, Vidal, J, Gibert, J, Fernández-Rodriguez, MC, Linares, J, Garcia-Alfonso, P, Páez, D, Alonso, V, Gomez-España, MA, Guix, M, Santos, C, Duran, G, Élez, E, Garcia-Carbonero, R, Ferreiro, R, Pineda, E, Sastre, J, Cano, MT, Manzano, JL, Losa, F, Aranda, E, Rivera, F, Sibilio, A, Toledo, R, Tabernero, J, Salazar, R, Bellosillo, B and Montagut, C.
Clinical validation of liquid biopsy-RECIST (LB-RECIST) in metastatic colorectal cancer (mCRC) patients: findings from the PLATFORM-B study
ESMO Open 10(9): 105760-105760
-
Pons, L, Hernandez, L, Urbizu, A, Arnaldo, L, Rodriguez-Martinez, P, Sanz, C, Munoz-Mármol, AM, Fernandez, E, Felip, E, Quiroga, V, Margelí, M and Fernandez, PL.
Molecular Landscape, Genomic Shift, and Prediction in the Neoadjuvant Setting of Human Epidermal Growth Factor Receptor 2ePositive Breast Cancer
Modern Pathology 38(9): 100787-100787
-
Felip, E, Garcia-Vidal, E, de las Heras, S, Bernat-Peguera, A, Cirauqui, B, Bergamino, M, Quiroga, V, Teruel, I, Ferrando-Díez, A, Pous, A, Lopez-Paradís, A, Boronat, L, Romeo, M, Mesía, R, Fernandez, PL, Clotet, B, Riveira-Muñoz, E, Martínez-Cardús, A, Ballana, E and Margelí, M.
Immune-based transcriptomic signature predicts CDK4/6 inhibitor efficacy in HR+/HER2-breast cancer
Clinical and Translational Medicine 15(8):
-
Rosell, A, Baeza, S, Mouriño, R, Saigi, M, Munne, M, de Castro, PL, Bechini, J, Estrada, O, Ara, J, Ricou, L and López-Segui, F.
A cost minimization analysis of the implementation of the international lung screening trial in Catalonia (Spain)
BMC Health Services Research 25(1): 1001-1001
-
de Luna, CJ, Gomez, AE, Pérez, OM, Estela, AC, Oliva, M, Borbalas, AL and Nin, RM.
Evidence and reality: an observational study on pharmacological outcomes in advanced head and neck tumors
Frontiers in Oncology 15: 1598125-1598125
-
Alsina, M, Villacampa, G, de Andrea, C, Vivancos, A, Ponz-Sarvise, M, Arrazubi, V, Jimenez-Fonseca, P, Diez, M, Sanz-Garcia, E, Martínez, E, Guardeño, R, Calvo, M, Bugés, C, Longo, F, Navarro, V, García-Galea, E, Gros, A, Ochoa, MC, Lopez-Janeiro, A, Sanchez-Gregorio, S, Herrero, C, Labiano, I, Vila-Casadesús, M, López, D, Alexandru, R, Muñoz, S, Tabernero, J and Melero, I.
A Phase II Study of Perioperative Avelumab plus Chemotherapy for Patients with Resectable Gastric Cancer or Gastroesophageal Junction Cancer - The MONEO Study
Clinical Cancer Research 31(14): 2890-2898
-
Agrawal, YN, Fernandez-Martinez, A, Gil-Gil, M, Zielinski, C, Ruiz-Borrego, M, Ciruelos, EM, Munoz, M, Margeli, M, Bermejo, B, Anton, A, Kahan, Z, Csoeszi, T, Alonso-Romero, JL, Garcia-Saenz, JA, Sanchez-Rovira, P, Alvarez, E, Chacon, JI, Gonzalez-Santiago, S, Rodriguez, CA, Servitja, S, Pfefferle, AD, Herranz, J, Liu, Y, Carey, LA, Romero-Camarero, I, Caballero, R, Guerrero-Zotano, A, Perou, CM and Martin, M.
Transcriptomic Predictors of Survival for Palbociclib plus Endocrine Therapy Versus Capecitabine in Aromatase Inhibitor-Resistant Breast Cancer From the GEICAM/2013-02 PEARL Trial
JCO Precision Oncology 9:
-
González-Gallego, C, Molina, P, Hostalot, C, Oliva, A, Blanco, A, de Pablo, PP, Comas, S, Carrato, C, Valassi, E and Puig-Domingo, M.
Modern treatment of craniopharyngioma to improve outcomes: evidence of a change of paradigm
Endocrine 89(1): 20-29
-
de Herreros, MG, Jiménez, N, Padrosa, J, Aversa, C, Ferrer-Mileo, L, García-Esteve, S, Rodríguez-Carunchio, L, Trias, I, Fernández-Mañas, L, Marín-Aguilera, M, Altamirano, M, Mazariegos, M, Font, A, Rodriguez-Vida, A, Climent, MA, Cros, S, Chirivella, I, Figols, M, Sala-González, N, de Porras, VR, Pardo, JC, Prat, A, Reig, O and Mellado, B.
Clinical and Transcriptomic Characterization of Metastatic Hormone-Sensitive Prostate Cancer Patients with Low PTEN Expression
International Journal of Molecular Sciences 26(13):
-
Nadal, E, Morán, T, Estival, A, Sala, MA, Antoñanzas, M, González, JG, Diz-Taín, MP, Martínez, M, Azcona, E, Baena, J, Campos, B, Cumplido, JD, Cerezo, S, Díaz-Serrano, A, Guirado, M, Mielgo, X, Saigí, M and Vidales, Z.
Observational study on the safety and effectiveness of SARS-CoV-2 vaccination in patients with lung cancer
Esmo Real World Data And Digital Oncology 8: 100125-100125
-
González-Barrallo, I, Rubio, VEC, Medina, J, Fernández, SE, Mujika, K, Majem, M, Aguado, C, Suárez, MAC, Palacio, I, Osterloh, L, Martinez-Fernández, A and García-Castaño, A.
Relation between dabrafenib plus trametinib-induced pyrexia and age in BRAF V600-mutated metastatic melanoma patients: A post hoc analysis of the real-world ELDERLYMEL study
Melanoma Research 35(3): 170-175
-
Choulli M, Morey F, Tous S, Brenes J, Wang X, Quirós B, González-Tampán AR, Pavón MA, Gomà M, Taberna M, Alemany ME, Oliva M, Mena M, Arribas L and Mesia R.
Exploring the role of human papillomavirus (HPV) status in body composition and nutritional features in patients with oropharyngeal cancer
Clinical Nutrition ESPEN 67: 417-426
-
Teixidor-Rodríguez, P, Brugada-Bellsolà, F, Menéndez-Girón, S, Parada-Arias, L, Hostalot-Panisello, C, Garcia-Armengol, R, Castañer-Llanes, S, Comas-Anton, S, Domenech-Viñolas, M, Carrato, C, Izquierdo, C, Busquets-Bonet, J, Domínguez-Alonso, CJ and Montané, E.
Periventricular gliomas: Evaluation of the risks associated with ventricular opening in two cohorts-one prospective with TachoSil® for ventricular sealing and the other without it retrospective
EJSO 51(6): 109670-109670
-
Tahara, M, Greil, R, Rischin, D, Harrington, KJ, Burtness, B, de Castro, G, Psyrri, A, Braña, I, Neupane, P, Bratland, A, Fuereder, T, Hughes, BGM, Mesía, R, Ngamphaiboon, N, Rordorf, T, Ishak, WZW, Lin, JX, Gumuscu, B, Lerman, N and Soulières, D.
Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: 5-year follow-up from the randomized phase III KEYNOTE-048 study
European Journal of Cancer 221: 115395-115395
-
McCoon, P, Wang, Y, Lai, ZW, Zhang, Q, Li, WM, Wildsmith, S, Morsli, N, Raja, R, Holoweckyj, N, Walker, J, de los Reyes, M, Mesia, R, Licitra, L, Ferris, RL, Fayette, J, Zandberg, DP, Siu, LL and Haddad, R.
Mutational Landscape of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Association with Immune Checkpoint Inhibitor Outcomes
Clinical Cancer Research 31(10): 1931-1942
-
Haddad, R, Fayette, J, Teixeira, M, Prabhash, K, Mesia, R, Kawecki, A, Dechaphunkul, A, Dinis, J, Guo, Y, Masuda, M, Hsieh, CY, Ghi, MG, Sette, CVD, Harrington, K, Tahara, M, Saba, NF, Lau, A, Jiang, T, Yan, YB, Ballinger, M, Kaul, M, Matheny, C, Cuchelkar, V and Wong, DJ.
Atezolizumab in High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck A Randomized Clinical Trial
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 333(18): 1599-1607
-
Nadal E, Martín-Martorell P, Benítez JC, Sala MÁ, Cedrés S, Álvarez C, Dómine M, Sais E, Saigí M, López R, Vilà L, Massutí B, García-Campelo R, Mesas-Ruiz A, Insa A, Plans-Marín S, Hijazo-Pechero S, Muñoz-Pinedo C, Brenes J and Provencio M.
Efficacy and safety of bintrafusp alfa evaluated in a phase II single-arm clinical trial in previously treated advanced pleural mesothelioma
Lung Cancer 203: 108545-108545
-
Salvia R, Rico LG, Morán T, Olszowy MW, Ward MD and Petriz J.
Evaluation of Blood Cytotoxicity Against Tumor Cells Using a Live-Cell Imaging Platform
Cytometry Part A 107(5): 344-352
-
Pla, H, Fullana, B, Esteve, A, Fort-Culillas, R, Ferrando-Díez, A, Fernández-Ortega, A, Pous, A, Stradella, A, Villanueva-Vázquez, R, Cirauqui, B, Falo, C, Martínez-Pérez, E, Molina, G, del Barco, S, Eraso, A, Margelí, M, Viñas, G, Gil-Gil, M, Petriz, L and Pernas, S.
Comprehensive Clinical Characterization and Long-Term Follow-Up of the Institut Catala d'Oncologia Breast Cancer Observational Cohort Study
Cancers 17(8):
-
Figols, M, Chekhun, S, Fernández-Saorin, M, Pérez-Criado, I, Bautista, A, Font, A and de Porras, VR.
Tumor-Educated Platelets in Urological Tumors: A Novel Biosource in Liquid Biopsy
International Journal of Molecular Sciences 26(8):
-
Szturz, P, Fuereder, T, Guo, Y, Licitra, L, Mesia, R, Ivanyi, P, Falco, A, Tahara, M, Solbes, MN, Venturini, F and Bossi, P.
Treatment decision-making factors and sequencing in recurrent and/or metastatic squamous cell carcinoma of the head and neck
Cancer Treatment Reviews 135: 102910-102910
-
Soo, RA, Vervita, K, Früh, M, Cho, B, Majem, M, Abreu, DR, Ribi, K, Callejo, A, Moran, T, Gomez, MD, Provencio, M, Addeo, A, Han, JY, Granados, ALO, Reck, M, Blasco, A, Campelo, RG, González, MAS, Britschgi, C, Roschitzki-Voser, H, Ruepp, B, Gasca-Ruchti, A, Haberecker, M, Dafni, U, Peters, S and Stahel, RA.
A randomised non-comparative phase II study of atezolizumab, bevacizumab and chemotherapy in EGFR-mutant NSCLC with acquired resistance - The ETOP 15-19 ABC-lung trial
Lung Cancer 202: 108454-108454
-
Vidal, M, Falato, C, Pascual, T, Sanchez-Bayona, R, Muñoz-Mateu, M, Cebrecos, I, Gonzalez-Farré, X, Cortadellas, T, Vila, MM, Luna, MA, Siso, C, Amillano, K, Galván, P, Bergamino, MA, Ferrero-Cafiero, JM, Salvador, F, Guerrero, AE, Pare, L, Sanfeliu, E, Prat, A and Bellet, M.
Elacestrant in Women with Estrogen Receptor-Positive and HER2-Negative Early Breast Cancer: Results from the Preoperative Window-of-Opportunity ELIPSE Trial
Clinical Cancer Research 31(7): 1223-1232
-
Samaniego-González, E, Podlipnik, S, Ribero, S, Nagore, E, Boada, A, Cañueto, J, Paradela, S, de Unamuno, B, Rodríguez-Jiménez, P, Puig, S, Malvehy, J, Carrera, C, Roccuzzo, G, Requena, C, Manrique-Silva, E, Richarz, N, Ruiz-Villanueva, A, Traves, V, España-Fernández, S, Botella-Estrada, R, González-Morán, MA and Tejera-Vaquerizo, A.
Multicenter Analysis of the Surgical Management and Adjuvant Therapy of Patients With Melanoma and a Positive Sentinel Lymph Node Biopsy
Actas Dermo-Sifiliograficas 116(3): 233-244
-
Margalef, NM, Mart, B, Martínez-Balibrea, E, Mozo, JLM, Borgognone, A and Obon-Santacana, M.
Microbiome as a predictive biomarker in locally advanced rectal cancer
Microbiome Research Reports 4(2): 18-18
-
Bosch-Barrera J, Estévez-García P, Martín-Martorell P, Sabatier R, Nadal E, Sais E, Gascón P, Oaknin A, Rodon J, Lizcano JM, Muñoz-Guardiola P, Fierro-Durán G, Pedrós-Gámez O, Pérez-Montoyo H, Yeste-Velasco M, Cortal M, Pérez-Campos A, Alfón J, Domènech C and Morán T.
ENDOLUNG trial, part II. A phase II study of the Akt/mTOR inhibitor and autophagy inducer ibrilatazar (ABTL0812) in combination with paclitaxel/ carboplatin in patients with squamous non-small cell lung cancer
Lung Cancer 201: 108105-108105
-
Sibai, M, Cervilla, S, Grases, D, Musulen, E, Lazcano, R, Mo, CK, Davalos, V, Fortian, A, Bernat, A, Romeo, M, Tokheim, C, Barretina, J, Lazar, AJ, Ding, L, Grande, E, Real, FX, Esteller, M, Bailey, MH and Porta-Pardo, E.
The spatial landscape of cancer hallmarks reveals patterns of tumor ecological dynamics and drug sensitivity
Cell Reports 44(2): 115229-115229
-
Garcia-Del-Muro X, P Valderrama B, Medina-Colmenero A, Etxaniz O, Gironés Sarrió R, Juan-Fita MJ, Costa-García M, Moreno R, Miras Rodríguez I, Ortiz I, Cuéllar A, Ferrer F, Vigués F, de Haro Piedra R, Candal Gomez A, Villà S, Pontones JL, Murria Y, Lendínez-Cano G and Alemany R.
Bladder Preservation with Durvalumab plus Tremelimumab and Concurrent Radiotherapy in Patients with Localized Muscle-Invasive Bladder Cancer (IMMUNOPRESERVE): A Phase II Spanish Oncology GenitoUrinary Group Trial
Clinical Cancer Research 31(4): 659-666
-
André, T, Elez, E, Lenz, HJ, Jensen, LH, Touchefeu, Y, Van Cutsem, E, Garcia-Carbonero, R, Tougeron, D, Mendez, GA, Schenker, M, de la Fouchardiere, C, Limon, ML, Yoshino, T, Li, J, Mozo, JLM, Dahan, L, Tortora, G, Chalabi, M, Goekkurt, E, Braghiroli, MI, Joshi, R, Cil, T, Aubin, F, Cela, E, Chen, T, Lei, M, Jin, LX, Blum, S and Lonardi, S.
Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial
LANCET 405(10476): 383-395
-
Muñoz-Mármol AM, Meléndez B, Hernandez A, Sanz C, Domenech M, Arpí-Llucia O, Gut M, Esteve A, Esteve-Codina A, Parra G, Carrato C, Aldecoa I, Mallo M, Pineda E, Alameda F, de la Iglesia N, Martinez-Balibrea E, Martinez-Cardús A, Estival-Gonzalez A and Balana C.
Multikinase Treatment of Glioblastoma: Evaluating the Rationale for Regorafenib
Cancers 17(3):
-
Huertas-Zurriaga, A, Cabrera-Jaime, S, Navarri, I, Teruel-Garcia, I and Leyva-Moral, JM.
Reconfiguring Priorities: Breastfeeding Decision-making Among Young Breast Cancer Survivors
Cancer Nursing :
-
Hughes BGM, Guminski A, Bowyer S, Migden MR, Schmults CD, Khushalani NI, Chang ALS, Grob JJ, Lewis KD, Ansstas G, Day F, Ladwa R, Stein BN, Muñoz Couselo E, Meier F, Hauschild A, Schadendorf D, Basset-Seguin N, Modi B, Dalac-Rat S, Dunn LA, Flatz L, Mortier L, Guégan S, Heinzerling LM, Mehnert JM, Trabelsi S, Soria-Rivas A, Stratigos AJ, Ulrich C, Wong DJ, Beylot-Barry M, Bossi P, Bugés Sánchez C, Chandra S, Robert C, Russell JS, Silk AW, Booth J, Yoo SY, Seebach F, Lowy I, Fury MG and Rischin D.
A phase 2 open-label study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (EMPOWER-CSCC-1): Final long-term analysis of groups 1, 2, and 3, and primary analysis of fixed-dose treatment group 6.
Journal of the American Academy of Dermatology 92(1): 68-77
-
Navarro-Sabaté, A, Font, R, Espinas, JA, Solà, J, Martínez-Soler, F, Gil-Gil, M, Viñas, G, Tibau, A, Borrell, M, Segui, M, Margelí, M, Servitja, S, Perez, C, Domenech, M, Nava, M, Marin, M, Gonzalez, S and Borràs, JM.
Evaluating the Quality of Real-World Data on Adherence to Oral Endocrine Therapy in Breast Cancer Patients: How Real Is Real-World Data?
Cancers 17(2):
-
Andúlar, JMC, de la Peña, FA, Vila, MM, Pascual, J, Tolos, P, Pages, C, Cuenca, N and Zotano, AG.
Optimizing therapeutic approaches for HR+/HER2advanced breast cancer: clinical perspectives on biomarkers and treatment strategies post-CDK4/6 inhibitor progression
Cancer Drug Resistance 8: 5-5
-
Cirauqui, BC, Peguera, AB, Pi-Sunyer, AQ, Ferrando-Díez, A, Serrano, JLR, Viñolas, MD, García, IT, García, VQ, Oukadour, IC, Valencia, AG, Vergara, PH, Egaña, ID, Herrero, CQ, Carbonell, OM, Paradís, AL, Esteve, A, Vila, MM, Rosell, R, Martínez-Cardús, A and Mesía, R.
Deciphering the impact of STAT3 activation mediated by PTPRT promoter hypermethylation as biomarker of response to paclitaxel-plus-cetuximab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK 47(1): 57-67
-
Cerezuela-Fuentes, P, Gonzalez-Cao, M, Puertolas, T, Manzano, JL, Maldonado, C, Yelamos, O, Berciano-Guerrero, MA, Martin-Liberal, J, Muñoz-Couselo, E, Espinosa, E, Drozdowskyj, A, Berrocal, A, Soria, A, Marquez-Rodas, I, Martin-Algarra, S, Quindos, M and Puig, S.
Access to systemic treatment of non-melanoma skin cancer in Spain: a survey analysis
CLINICAL & TRANSLATIONAL ONCOLOGY 27(1): 386-391
-
Choulli, M, Kubrak, C, Morey, F, Brenes, J, Tous, S, Quirós, B, Wang, X, Pavón, MA, Gomà, M, Taberna, M, Alemany, L, Oliva, M, Mena, M, Jha, N, Scrimger, R, Debenham, B, Chua, N, Walker, J, Mesia, R, Baracos, V and Arribas, L.
Nutritional characterization of patients with oropharyngeal cancers: impact of human papillomavirus status
European Journal of Clinical Nutrition 79(5): 467-474
-
González-Martín, A, Rubio, MJ, Heitz, F, Christensen, RD, Colombo, N, Van Gorp, T, Romeo, M, Ray-Coquard, I, Gaba, L, Leary, A, De Sande, LM, Lebreton, C, Redondo, A, Fabbro, M, Ginesta, MPB, Follana, P, Pérez-Fidalgo, JA, Rodrigues, M, Santaballa, A, Sabatier, R, Bermejo-Pérez, MJ, Lotz, JP, Pardo, B, Marquina, G, Sánchez-Lorenzo, L, Quindós, M, Estévez-García, P, Alía, EG, Manso, L, Casado, V, Kommoss, S, Tognon, G, Henry, S, Bruchim, I, Oaknin, A and Selle, F.
Atezolizumab Combined With Platinum and Maintenance Niraparib for Recurrent Ovarian Cancer With a Platinum-Free Interval >6 Months: ENGOT-OV41/GEICO 69-O/ANITA Phase III Trial
JOURNAL OF CLINICAL ONCOLOGY 42(36): 4294-4304
-
de Herreros, MG, Jiménez, N, Rodríguez-Carunchio, L, Lillo, E, Marín-Aguilera, M, Ferrer-Mileo, L, Aversa, C, García-Esteve, S, Padrosa, J, Trias, I, Fernández-Mañas, L, Font, A, Chirivella, I, Figols, M, Climent, MA, Prat, A, Reig, O and Mellado, B.
Prognostic Expression Signature of RB1, PTEN, and TP53 Genes in Patients with Metastatic Hormone-sensitive Prostate Cancer Treated with Androgen Receptor Pathway Inhibitors
European Urology Open Science 70: 86-90
-
Andre, T, Elez, E, Van Cutsem, E, Jensen, LH, Bennouna, J, Mendez, G, Schenker, M, de la Fouchardiere, C, Limon, ML, Yoshino, T, Li, J, Lenz, HJ, Mozo, JLM, Tortora, G, Garcia-Carbonero, R, Dahan, L, Chalabi, M, Joshi, R, Goekkurt, E, Braghiroli, MI, Cil, T, Cela, E, Chen, T, Lei, M, Dixon, M, Abdullaev, S and Lonardi, S.
Nivolumab plus Ipilimumab in Microsatellite-Instability-High Metastatic Colorectal Cancer
New England Journal of Medicine 391(21): 2014-2026
-
Llop, S, Plana, M, Tous, S, Ferrando-Diez, A, Brenes, J, Juarez, M, Vidales, Z, Vilajosana, E, Linares, I, Arribas, L, Duch, M, Fulla, M, Brunet, A, Lozano, A, Cirauqui, B, Mesía, R and Oliva, M.
Salvage chemotherapy after progression on immunotherapy in recurrent/metastatic squamous cell head and neck carcinoma
Frontiers in Oncology 14:
-
Teruel, I, Castellà, E, Recalde, S, Viñas, G, Petit, A, Trigueros, M, Martínez-Balibrea, E, Felip, E, Bergamino, M, Bernat-Peguera, A, Cirauqui, B, Quiroga, V, Ferrando-Díez, A, Pous, A, López, A, Boronat, L, Soler, G, Recuero, J, Romeo, M, Guillén, P, Mesía, R, Ballana, E, Martínez-Cardús, A and Margelí, M.
Assessing the Prognostic Value of Cytoplasmic and Stromal Caveolin-1 in Early Triple-Negative Breast Cancer Undergoing Neoadjuvant Chemotherapy
International Journal of Molecular Sciences 25(22):
-
Gutiérrez-García, B, Cáceres, CM, Núñez-Marín, F, Molero, J, Prats, L, Mestre, N, Martínez, S, Teixidor, P, Comas, S, Balañà, C and Villà, S.
Early region-specific impact of adjuvant radiation therapy on cognition and quality of life in adult patients with primary brain tumors
CLINICAL & TRANSLATIONAL ONCOLOGY 27(5): 2143-2159
-
Gonzalez-Cao, M, Puertolas, T, Manzano, JL, Maldonado, C, Yelamos, O, Berciano-Guerrero, MA, Cerezuela, P, Martin-Liberal, J, Muñoz-Couselo, E, Espinosa, E, Drozdowskyj, A, Berrocal, A, Soria, A, Marquez-Rodas, I, Martin-Algarra, S, Quindos, M and Puig, S.
Access to melanoma drugs in Spain: a cross-sectional survey
CLINICAL & TRANSLATIONAL ONCOLOGY 26(10): 2572-2583
-
Candal-Pedreira, C, Ruano-Ravina, A, de Juan, VC, Cobo, M, Cantero, A, Rodríguez-Abreu, D, Estival, A, Carcereny, E, Hernandez, A, Castro, RL, Medina, A, Campelo, RG, Bruno, MF, Barnabé, R, Bosch-Barrera, J, Massutí, B, Dómine, M, Camps, C, Ortega, AL and Provencio, M.
Analysis of Diagnostic Delay and its Impact on Lung Cancer Survival: Results From the Spanish Thoracic Tumor Registry
Archivos de Bronconeumologia 60: 38-45
-
Romero-Clarà, O, Madrid, C, Pardo, JC, de Porras, VR, Etxaniz, O, Moreno-Alonso, D and Font, A.
E-learning pills on immunotherapy in urothelial carcinoma: The E-PIMUC program for continuing medical education
Frontiers in Pharmacology 15:
-
Coleman, RL, Lorusso, D, Oaknin, A, Cecere, SC, Denys, H, Colombo, N, van Gorp, T, Konner, JA, Marin, MR, Harter, P, Murphy, C, Wang, YM, Esteves, B, Method, M and Matulonis, U.
Mirvetuximab soravtansine in folate receptor alpha (FRa)-high platinum-resistant ovarian cancer: final overall survival and post hoc sequence of therapy subgroup results from the SORAYA trial
International Journal of Gynecological Cancer 34(8): 1119-1125
-
Querol, JM, Jurado-Bruggeman, D, Lopez-Vidal, A, Nin, RM, Rubió-Casadevall, J, Buxó, M and Urien, AE.
Contouring aid tools in radiotherapy. Smoothing: the false friend
CLINICAL & TRANSLATIONAL ONCOLOGY 26(8): 1956-1967
-
Jiménez, N, de Herreros, MG, Reig, O, Marin-Aguilera, M, Aversa, C, Ferrer-Mileo, L, Garcia-Esteve, S, Rodríguez-Carunchio, L, Trias, I, Font, A, Rodríguez-Vida, A, Climent, MA, Cros, S, Chirivella, I, Domènech, M, Figols, M, Carles, J, Suarez, C, Rivera, DH, González-Billalabeitia, E, Cívico, C, Sala-González, N, de Porras, VR, Ribal, MJ, Prat, A and Mellado, B.
Development and Independent Validation of a Prognostic Gene Expression Signature Based on RB1, PTEN, and TP53 in Metastatic Hormone-sensitive Prostate Cancer Patients
European urology oncology 7(4): 954-964
-
Leary, A, Estévez-García, P, Sabatier, R, Ray-Coquard, I, Romeo, M, Barretina-Ginesta, P, Gil-Martin, M, Garralda, E, Bosch-Barrera, J, Morán, T, Martin-Martorell, P, Nadal, E, Gascón, P, Rodon, J, Lizcano, JM, Muñoz-Guardiola, P, Fierro-Durán, G, Pedrós-Gámez, O, Pérez-Montoyo, H, Yeste-Velasco, M, Cortal, M, Pérez-Campos, A, Alfon, J, Domenech, C, Pérez-Fidalgo, A and Oaknin, A.
ENDOLUNG trial. A phase 1/2 study of the Akt/mTOR inhibitor and autophagy inducer Ibrilatazar (ABTL0812) in combination with paclitaxel/carboplatin in patients with advanced/recurrent endometrial cancer
BMC Cancer 24(1):
-
Brasó-Maristany, F, Ferrero-Cafiero, JM, Falato, C, Martínez-Sáez, O, Cejalvo, JM, Margeli, M, Tolosa, P, Salvador-Bofill, FJ, Cruz, J, González-Farré, B, Sanfeliu, E, Odena, A, Serra, V, Pardo, F, Barrera, AML, Arumi, M, Guerra, JA, Villacampa, G, Sánchez-Bayona, R, Ciruelos, E, Espinosa-Bravo, M, Izarzugaza, Y, Galván, P, Matito, J, Pernas, S, Vidal, M, Santhanagopal, A, Sellami, D, Esker, S, Fan, PD, Suto, F, Vivancos, A, Pascual, T, Prat, A and Oliveira, M.
Patritumab deruxtecan in HER2-negative breast cancer: part B results of the window-of-opportunity SOLTI-1805 TOT-HER3 trial and biological determinants of early response
Nature Communications 15(1):
-
Pla, H, Felip, E, Obadia, V, Pernas, S, Viñas, G, Margelí, M, Fort-Culillas, R, Del Barco, S, Sabaté, N, Fort, E, Lezcano, C, Cirauqui, B, Quiroga, V, Stradella, A, Gil, MG, Esteve, A and Recalde, S.
Elderly patients with hormone receptor-positive HER2-negative metastatic breast cancer treated with CDK4/6 inhibitors in a multicentre cohort
CLINICAL & TRANSLATIONAL ONCOLOGY 26(7): 1748-1758
-
Perez-Navarro, E, Conteduca, V, Funes, JM, Dominguez, JI, Martin-Serrano, M, Cremaschi, P, Fernandez-Perez, M, Gordoa, TA, Font, A, Vázquez-Estévez, S, González-del-Alba, A, Wetterskog, D, Mellado, B, Fernandez-Calvo, O, Méndez-Vidal, M, Climent, M, Duran, I, Gallardo, E, Sanchez, A, Santander, C, Sáez, M, Puente, J, Tudela, J, Marinas, C, López-Andreo, M, Castellano, D, Attard, G, Grande, E, Rosino, A, Botia, JA, Palma-Mendez, J, De Giorgi, U and Gonzalez-Billalabeitia, E.
Prognostic Implications of Blood Immune-Cell Composition in Metastatic Castration-Resistant Prostate Cancer
Cancers 16(14):
-
Roure, S, Valles, X, Perez-Quilez, O, Lopez-Munoz, I, Chamorro, A, Abad, E, Valerio, L, Soldevila, L, Gorriz, E, Herena, D, Pedregal, EF, Espana, S, Serra, C, Cera, R, Rodriguez, AM, Serrano, L, Falguera, G, Hegazy, AHA, Fernandez-Rivas, G, Miralles, C, Conde, C, Montero-Alia, JJ, Miranda-Sanchez, J, Llibre, JM, Isnard, M, Bonet, JM, Estrada, O, Prat, N and Clotet, B.
Female genitourinary schistosomiasis-related symptoms in long-term sub-Saharan African migrants in Europe: a prospective population-based study
Journal of Travel Medicine 31(6):
-
Roure, S, Vallès, X, Pérez-Quílez, O, López-Muñoz, I, Chamorro, A, Abad, E, Valerio, L, Soldevila, L, España, S, Hegazy, AHA, Fernández-Rivas, G, Gorriz, E, Herena, D, Oliveira, M, Miralles, MC, Conde, C, Montero-Alia, JJ, Fernández-Pedregal, E, Miranda-Sánchez, J, Llibre, JM, Isnard, M, Bonet, JM, Estrada, O, Prat, N and Clotet, B.
Male genitourinary schistosomiasis-related symptoms among long-term Western African migrants in Spain: a prospective population-based screening study
Infectious Diseases of Poverty 13(1):
-
Saigi, M, Mate, JL, Carcereny, E, Martinez-Cardus, A, Esteve, A, Andreo, F, Centeno, C, Cucurull, M, Mesia, R, Pros, E and Sanchez-Cespedes, M.
HLA-I levels correlate with survival outcomes in response to immune checkpoint inhibitors in non-small cell lung cancer
Lung Cancer 189:
-
Sun, C, España, S, Richarz, N, Solé-Blanch, C, Boada, A, Martinez-Cardús, A, Chu, AL, Liu, ZW and Manzano, JL.
Targeted therapy or immunotherapy in BRAF-mutated metastatic melanoma: a Spanish center's decade of experience
Frontiers in Oncology 14:
-
Mostaghim, A, Minkove, S, Aguilar-Company, J, Ruiz-Camps, I, Eremiev-Eremiev, S, Dettorre, GM, Fox, L, Tondini, C, Brunet, J, Carmona-García, M, Lambertini, M, Bower, M, Newsom-Davis, T, Sharkey, R, Dalla Pria, A, Rossi, M, Plaja, A, Salazar, R, Sureda, A, Prat, A, Michalarea, V, Van Hemelrijck, M, Sita-Lumsden, A, Bertuzzi, A, Rimassa, L, Rossi, S, Rizzo, G, Pedrazzoli, P, Lee, AJ, Murphy, C, Belessiotis, K, Diamantis, N, Mukherjee, U, Pommeret, F, Stoclin, A, Martinez-Vila, C, Bruna, R, Gaidano, G, D'Avanzo, F, Gennari, A, Athale, J, Eichacker, P, Pinato, DJ, Torabi-Parizi, P and Cortellini, A.
Previous immune checkpoint inhibitor therapy is associated with decreased COVID-19-related hospitalizations and complications in patients with cancer: Results of a propensity-matched analysis of the OnCovid registry
International Journal of Infectious Diseases 139: 13-20
-
Bharathan, R, Polterauer, S, Lopez-Sanclemente, MC, Trukhan, H, Pletnev, A, Heredia, AG, Gil, MM, Bakinovskaya, I, Dalamanava, A, Romeo, M, Rovski, D, Baquedano, L, Chiva, L, Schwameis, R and Zapardiel, I.
Prognostic Value of Lymph Node Ratio in Patients with Uterine Carcinosarcoma
Journal of Personalized Medicine 14(2):
-
Indacochea, A, Guitart, T, Boada, A, Peg, V, Quer, A, Laayouni, H, Condal, L, Espinosa, P, Manzano, JL and Gebauer, F.
CSDE1 Intracellular Distribution as a Biomarker of Melanoma Prognosis
International Journal of Molecular Sciences 25(4):
-
Candal-Pedreira, C, Ruano-Ravina, A, Juan, VCD, Cobo, M, Trigo, JM, Rodríguez-Abreu, D, Estival, A, Carcereny, E, Cucurull, M, Castro, RL, Medina, A, Campelo, RG, Gonzalez, PC, Sánchez-Gastaldo, A, Bosch-Barrera, J, Massuti, B, Dómine, M, Camps, C, Ortega, AL, Sánchez-Hernandez, A, Risueño, MG, Morillo, ED, Fernández, AG and Provencio, M.
Comparison of Clinical and Genetic Characteristics Between Younger and Older Lung Cancer Patients
Archivos de Bronconeumologia 60(2): 88-94
-
Gorria, T, Crous, C, Pineda, E, Hernandez, A, Domenech, M, Sanz, C, Jares, P, Muñoz-Mármol, AM, Arpí-Llucia, O, Melendez, B, Gut, M, Esteve, A, Esteve-Codina, A, Parra, G, Alameda, F, Carrato, C, Aldecoa, I, Mallo, M, de la Iglesia, N and Balana, C.
The C250T Mutation of TERTp Might Grant a Better Prognosis to Glioblastoma by Exerting Less Biological Effect on Telomeres and Chromosomes Than the C228T Mutation
Cancers 16(4):
-
Gutiérrez-Chamorro, L, Felip, E, Castella, E, Quirogà, V, Ezeonwumelu, IJ, Angelats, L, Esteve, A, Perez-Roca, L, Martínez-Cardús, A, Fernandez, PL, Ferrando-Díez, A, Pous, A, Bergamino, M, Cirauqui, B, Romeo, M, Teruel, I, Mesia, R, Clotet, B, Riveira-Munoz, E, Margelí, M and Ballana, E.
SAMHD1 expression is a surrogate marker of immune infiltration and determines prognosis after neoadjuvant chemotherapy in early breast cancer
Cellular Oncology 47(1): 189-208
-
Carrato A, Pazo-Cid R, Macarulla T, Gallego J, Jiménez-Fonseca P, Rivera F, Cano MT, Rodriguez-Garrote M, Pericay C, Alés I, Layos L, Graña B, Iranzo V, Gallego I, Garcia-Carbonero R, de Mena IR, Guillén-Ponce C and Aranda E.
Nab-Paclitaxel plus Gemcitabine and FOLFOX in Metastatic Pancreatic Cancer.
Nejm Evidence 3(2):
-
de Porras, VR, Bernat-Peguera, A, Alcon, C, Laguia, F, Fernández-Saorin, M, Jiménez, N, Senan-Salinas, A, Solé-Blanch, C, Feu, A, Marín-Aguilera, M, Pardo, JC, Ochoa-de-Olza, M, Montero, J, Mellado, B and Font, A.
Dual inhibition of MEK and PI3Kß/d-a potential therapeutic strategy in PTEN-wild-type docetaxel-resistant metastatic prostate cancer
Frontiers in Pharmacology 15:
-
Pous, A, Bernat-Peguera, A, López-Paradís, A, Cirauqui, B, Quiroga, V, Teruel, I, Felip, E, Ferrando-Díez, A, Bergamino, M, Boronat, L, Romeo, M, Soler, G, Mariño, C, Rodríguez-Martínez, P, Pons, L, Ballana, E, Martinez-Cardús, A and Margelí, M.
Deciphering HER2-low breast cancer (BC): insights from real-world data in early stage breast cancer
Therapeutic Advances in Medical Oncology 16:
-
Tavira, B, Iscar, T, Manso, L, Santaballa, A, Gil-Martin, M, García García, Y, Romeo, M, Iglesias, M, Ferré, AD, Barretina-Ginesta, MP, Manzano, A, Gaba, L, Rubio, MJ, de Andrea, CE and González-Martín, A.
Analysis of Tumor Microenvironment Changes after Neoadjuvant Chemotherapy with or without Bevacizumab in Advanced Ovarian Cancer (GEICO-89T/MINOVA Study)
Clinical Cancer Research 30(1): 176-186
-
Cerdà, G, Julià-Torras, J, González-Barboteo, J, Romeo, M and Calsina-Berna, A.
Polypharmacy and Reversible Drug Induced QT Prolongation in a Patient with Advanced Cancer: Case Report
JOURNAL OF PAIN & PALLIATIVE CARE PHARMACOTHERAPY 38(1): 33-37
-
Font, A, Mellado, B, Climent, MA, Virizuela, JA, Oudard, S, Puente, J, Castellano, D, González-del-Alba, A, Pinto, A, Morales-Barrera, R, Rodriguez-Vida, A, Fernandez, PL, Teixido, C, Jares, P, Aldecoa, I, Gibson, N, Solca, F, Mondal, S, Lorence, RM, Serra, J and Real, FX.
Phase II trial of afatinib in patients with advanced urothelial carcinoma with genetic alterations in ERBB1-3 (LUX-Bladder 1)
British Journal of Cancer 130(3): 434-441
-
Postel-Vinay, S, Coves, J, Texier, M, Aldea, M, Gazzah, A, Domine, M, Planchard, D, De Las Peñas, R, Gonzalez, MAS, Viteri, S, Perez, J, Ortega, AL, Moran, T, Camps, C, Lopez-Martin, A, Provencio, M, Soria, JC, Besse, B, Massuti, B and Rosell, R.
Olaparib maintenance versus placebo in platinum-sensitive non-small cell lung cancer: the Phase 2 randomized PIPSeN trial
British Journal of Cancer 130(3): 417-424
-
Pesántez, D, ten Hoorn, S, Machado, I, García-Albéniz, X, Rodríguez-Salas, N, Heredia-Soto, V, Viñal, D, Pericay, C, García-Carbonero, R, Losa, F, Alonso, V, Vera, R, Batlle, JF, Gallego, J, Salud, A, Nogué, M, Layos, L, Montagut, C, Capdevila, J, Vermeulen, L, Maurel, J and Fernandez-Martos, C.
Total neoadjuvant therapy with or without aflibercept in rectal cancer: 3-year results of GEMCAD-1402
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE 115(12): 1497-1505
-
Aparicio, I, Iranzo, P, Reyes, R, Bote, H, Saigi, M, Bringas, M, Bosch-Barrera, J, Corral, J, Aparisi, F, Ruffinelli, JC, Jimenez, B, Lage, Y, López-Castro, R, Majem, M, Vázquez, S, Artal, A, Rodríguez-Pérez, A, Lázaro-Quintela, M, Torres, JMS, Reguart, N, Cucurull, M, Gil-Bazo, I, Camps, C, Nadalj, E, del Barrio, A, Garrido, P, Dómine, M, Alvarez, R, Muñoz, AJ and Calles, A.
Brief report: High incidence of peridiagnosis thromboembolic events in patients with BRAF-mutant lung cancer
Thrombosis Research 232: 133-137
-
de Porras, VR, Figols, M, Font, A and Pardina, E.
Curcumin as a hepatoprotective agent against chemotherapy-induced liver injury
Life Sciences 332:
-
Pascual, J, Gil-Gil, M, Proszek, P, Zielinski, C, Reay, A, Ruiz-Borrego, M, Cutts, R, Gil, EMC, Feber, A, Muñoz-Mateu, M, Swift, C, Bermejo, B, Herranz, J, Vila, MM, Antón, A, Kahan, Z, Csöszi, T, Liu, Y, Fernandez-Garcia, D, Garcia-Murillas, I, Hubank, M, Turner, NC and Martín, M.
Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients
Clinical Cancer Research 29(20): 4166-4177
-
Besse, B, Felip, E, Campelo, RG, Cobo, M, Mascaux, C, Madroszyk, A, Cappuzzo, F, Hilgers, W, Romano, G, Denis, F, Viteri, S, Debieuvre, D, Galetta, D, Baldini, E, Razaq, M, Robinet, G, Maio, M, Delmonte, A, Roch, B, Masson, P, Schuette, W, Zer, A, Remon, J, Costantini, D, Vasseur, B and Dziadziuszko, R.
Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1
Annals of Oncology 34(10): 920-933
-
Berenguer, M, Vergara, M, Almohalla, C, Hernandez, A, Blanco, S, Testillano, M, Girona, E, Casado, M, García, M, Catalina, MV, Muñoz, C, Gutierrez, ML, Molina, E, Romero, M, Otero, A, Hernáez-Alsina, T, Bernal-Monterde, V, Lorente, S, Masnou, H, Bonet, L, Soto, S, Gisbert, C, Valer, MP, Gomez, J, Pacheco, G, Morillas, J, Gonzalez, M, Dominguez, N, Lazaro, M, Pascual, S and Castelló, I.
Significant heterogeneity in the diagnosis and long-term management of Wilson disease: Results from a large multicenter Spanish study
Gastroenterologia y Hepatologia 46(8): 577-584
-
Garcia-Saenz, JA, Blancas, I, Echavarria, I, Hinojo, C, Margeli, M, Moreno, F, Pernas, S, Cajal, TRY, Ribelles, N and Bellet, M.
SEOM-GEICAM-SOLTI clinical guidelines in advanced breast cancer (2022)
CLINICAL & TRANSLATIONAL ONCOLOGY 25(9): 2665-2678
-
Abida, W, Campbell, D, Patnaik, A, Bryce, AH, Shapiro, J, Bambury, RM, Zhang, JS, Burke, JM, Castellano, D, Font, A, Ganju, V, Hardy-Bessard, AC, McDermott, R, Sautois, B, Spaeth, D, Voog, E, Piulats, JM, Pintus, E, Ryan, CJ, Merseburger, AS, Daugaard, G, Heidenreich, A, Fizazi, K, Loehry, A, Despain, D, Simmons, AD, Dowsonz, M, Goy, J, Watkinsz, SP and Chowdhury, S.
Rucaparib for the Treatment of Metastatic Castration-resistant Prostate Cancer Associated with a DNA Damage Repair Gene Alteration: Final Results from the Phase 2 TRITON2 Study
European Urology 84(3): 321-330
-
Linares, I, Frances, MAB, Cañas, R, Najjari, D, Gutiérrez, C, Marín, S, Comas, S, Guedea, F and Pujol, M.
Brachytherapy for targeting the immune system in cervical cancer patients
BMC Immunology 24(1):
-
Font, A, Domenech, M, Ramirez, JL, Marqués, M, Benítez, R, de Porras, VR, Gago, JL, Carrato, C, Sant, F, Lopez, H, Castellano, D, Malats, N, Calle, ML and Real, FX.
Predictive signature of response to neoadjuvant chemotherapy in muscle-invasive bladder cancer integrating mRNA expression, taxonomic subtypes, and clinicopathological features
Frontiers in Oncology 13:
-
Rubió-Casadevall, J, Cirauqui, BC, Trufero, JM, Serrahima, MP, Castaño, AG, Maseda, AC, Docampo, LI, Segura, PP, Lenza, IC, Calderón, VG, Salvà, JF, Alvarez, CP, Hernandez, I, Morillo, ED, Conde, MC, Galán, JM, Sánchez, MD, Quiroga, V, Ortega, E and Mesia, R.
TTCC-2019-02: real-world evidence of first-line cetuximab plus paclitaxel in recurrent or metastatic squamous cell carcinoma of the head and neck
Frontiers in Oncology 13:
-
Oliveira, M, Falato, C, Cejalvo, JM, Vila, MM, Tolosa, P, Salvador-Bo, FJ, Cruz, J, Arumi, M, Luna, AM, Guerra, JA, Vidal, M, Martínez-Sáez, O, Paré, L, González-Farré, B, Sanfeliu, E, Ciruelos, E, Espinosa-Bravo, M, Pernas, S, Izarzugaza, Y, Esker, S, Fan, PD, Parul, P, Santhanagopal, A, Sellami, D, Villacampa, G, Ferrero-Cafiero, JM, Pascual, T and Prat, A.
Patritumab deruxtecan in untreated hormone receptor-positive/HER2-negative early breast cancer: final results from part A of the window-of- opportunity SOLTI TOT-HER3 pre-operative study
Annals of Oncology 34(8): 670-680
-
Fontanals, S, Esteve, A, Gonzalez, A, Ibanez, C, Martinez, J, Mesia, R and Clopes, A.
Real-world treatment outcomes of medicines used in special situations (off-label and compassionate use) in oncology and hematology: A retrospective study from a comprehensive cancer institution
Cancer Medicine 12(16): 17112-17125
-
Marruecos-Querol, J, Rubio-Casadevall, J, Lozano, A, Buxo, M, Puigdemont, M, Linares, I, Planas, I, Vayreda, J, Cirauqui, B, Taberna, M, Quiroga, V, Tobed, M, Bores, A, Recalde, S, Saigi, M, Felip, E, Eraso, A and Mesia, R.
Validation of a prognostic model for predicting larynx preservation outcome (TALK score) in a Southern European population
CLINICAL & TRANSLATIONAL ONCOLOGY 25(8): 2384-2392
-
Pérez, OM, Benavides, JM, Fernandez, TG, Prio, SG, Domínguez, RR, Nin, RM and Estela, AC.
Is ranitidine necessary as premedication for regimens containing paclitaxel? A non-inferiority study
Expert Review of Clinical Pharmacology :
-
Plaja, A, Teruel, I, Ochoa-de-Olza, M, Cucurull, M, Arroyo, AJ, Pardo, B, Ortiz, I, Gil-Martin, M, Piulats, JM, Pla, H, Fina, C, Carbo, A, Barretina-Ginesta, MP, Martinez-Roman, S, Carballas, E, Gonzalez, A, Esteve, A and Romeo, M.
Prognostic Role of Neutrophil, Monocyte and Platelet to Lymphocyte Ratios in Advanced Ovarian Cancer According to the Time of Debulking Surgery
International Journal of Molecular Sciences 24(14):
-
Wildsmith, S, Li, WM, Wu, S, Stewart, R, Morsli, N, Raja, R, Zhang, Q, Ye, JB, He, PL, Shetty, J, Yovine, A, Holoweckyj, N, Real, K, Walker, J, Wrona, M, de los Reyes, M, Barker, C, Whiteley, J, Haddad, R, Licitra, L, Ferris, R, Fayette, J, Zandberg, DP, Siu, LL and Mesia, R.
Tumor Mutational Burden as a Predictor of Survival with Durvalumab and/or Tremelimumab Treatment in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Clinical Cancer Research 29(11): 2066-2074
-
Pons, L, Hernandez, L, Urbizu, A, Osorio, P, Rodriguez-Martinez, P, Castella, E, Munoz, A, Sanz, C, Arnaldo, L, Felip, E, Quiroga, V, Tapia, G, Margeli, M and Fernandez, PL.
Pre- and Post-Neoadjuvant Clinicopathological Parameters Can Help in the Prognosis and the Prediction of Response in HER2+and Triple Negative Breast Cancer
Cancers 15(12):
-
Capdevila, J, Hernando, J, Teule, A, Lopez, C, Garcia-Carbonero, R, Benavent, M, Custodio, A, Garcia-Alvarez, A, Cubillo, A, Alonso, V, Carmona-Bayonas, A, Alonso-Gordoa, T, Crespo, G, Jimenez-Fonseca, P, Blanco, M, Viudez, A, La Casta, A, Sevilla, I, Segura, A, Llanos, M, Landolfi, S, Nuciforo, P and Manzano, JL.
Durvalumab plus tremelimumab for the treatment of advanced neuroendocrine neoplasms of gastroenteropancreatic and lung origin
Nature Communications 14(1):
-
Tagliamento, M, Gennari, A, Lambertini, M, Salazar, R, Harbeck, N, Del Mastro, L, Aguilar-Company, J, Bower, M, Sharkey, R, Dalla Pria, A, Plaja, A, Jackson, A, Handford, J, Sita-Lumsden, A, Martinez-Vila, C, Matas, M, Rodriguez, AM, Vincenzi, B, Tonini, G, Bertuzzi, A, Brunet, J, Pedrazzoli, P, D'Avanzo, F, Biello, F, Sinclair, A, Lee, AJX, Rossi, S, Rizzo, G, Mirallas, O, Pimentel, I, Iglesias, M, de Torre, AS, Guida, A, Berardi, R, Zambelli, A, Tondini, C, Filetti, M, Mazzoni, F, Mukherjee, U, Diamantis, N, Parisi, A, Aujayeb, A, Prat, A, Libertini, M, Grisanti, S, Rossi, M, Zoratto, F, Generali, D, Saura, C, Lyman, GH, Kuderer, NM, Pinato, DJ and Cortellini, A.
Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast Cancer
JOURNAL OF CLINICAL ONCOLOGY 41(15): 2800
-
Matulonis, UA, Lorusso, D, Oaknin, A, Pignata, S, Dean, A, Denys, H, Colombo, N, Van Gorp, T, Konner, JA, Marin, MR, Harter, P, Murphy, CG, Wang, JZ, Noble, E, Esteves, B, Method, M and Coleman, RL.
Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study
JOURNAL OF CLINICAL ONCOLOGY 41(13): 2436
-
Ferrando-Díez, A, Pavón, MA, Cirauqui, B, Alemany, L and Mesía, R.
How to prevent human papillomavirus-related oropharyngeal cancer?
Current Opinion in Oncology 35(3): 145-150
-
Carbonell, C, Frigola, J, Pardo, N, Callejo, A, Iranzo, P, Valdivia, A, Priano, I, Cedres, S, Martinez-Marti, A, Navarro, A, Lenza, L, Soleda, M, Gonzalo-Ruiz, J, Vivancos, A, Sanso, M, Carcereny, E, Moran, T, Amat, R and Felip, E.
Dynamic changes in circulating tumor DNA assessed by shallow whole-genome sequencing associate with clinical efficacy of checkpoint inhibitors in NSCLC
Molecular Oncology 17(5): 779-791
-
Olivera-Salguero, R, Seguí, E, Cejalvo, JM, Oliveira, M, Tolosa, P, Vidal, M, Malumbres, M, Gavilá, J, Saura, C, Pernas, S, López, R, Margelí, M, Balmaña, J, Muñoz, M, Blancas, I, Boni, V, Ciruelos, E, Galve, E, Perelló, A, Sánchez-Bayona, R, de la Cruz, S, de la Hoya, M, Galván, P, Sanfeliu, E, Gonzalez-Farre, B, Sirenko, V, Blanch-Torras, A, Canes, J, Masanas, H, Olmos, R, Forns, M, Prat, A, Casas, A and Pascual, T.
HOPE (SOLTI-1903) breast cancer study: real-world, patient-centric, clinical practice study to assess the impact of genomic data on next treatment decision-choice in patients with locally advanced or metastatic breast cancer
Frontiers in Oncology 13:
-
Alburquerque-Bejar, JJ, Navajas-Chocarro, P, Saigi, M, Ferrero-Andres, A, Morillas, JM, Vilarrubi, A, Gomez, A, Mate, J, Munoz-Marmol, AM, Romero, OA, Blecua, P, Davalos, V, Esteller, M, Pros, E, Llabata, P, Torres-Diz, M, Esteve-Codina, A and Sanchez-Cespedes, M.
MYC activation impairs cell-intrinsic IFNy signaling and confers resistance to anti-PD1/PD-L1 therapy in lung cancer
Cell Reports Medicine 4(4):
-
Guerrero-Zotano, A, Belli, S, Zielinski, C, Gil-Gil, M, Fernandez-Serra, A, Ruiz-Borrego, M, Gil, EMC, Pascual, J, Muñoz-Mateu, M, Bermejo, B, Vila, MM, Antón, A, Murillo, L, Nissenbaum, B, Liu, Y, Herranz, J, Fernández-García, D, Caballero, R, López-Guerrero, JA, Bianco, R, Formisano, L, Turner, N and Martín, M.
CCNE1 and PLK1 Mediate Resistance to Palbociclib in HR+/HER2-Metastatic Breast Cancer
Clinical Cancer Research 29(8): 1557-1568
-
Cortellini, A, Tabernero, J, Mukherjee, U, Salazar, R, Sureda, A, Maluquer, C, Ferrante, D, Bower, M, Sharkey, R, Mirallas, O, Plaja, A, Cucurull, M, Mesia, R, Dalla Pria, A, Newsom-Davis, T, Van Hemelrijck, M, Sita-Lumsden, A, Apthorp, E, Vincenzi, B, Fazio, GRD, Tonini, G, Pantano, F, Bertuzzi, A, Rossi, S, Brunet, J, Lambertini, M, Pedrazzoli, P, Biello, F, D'Avanzo, F, Lee, AJX, Shawe-Taylor, M, Rogers, L, Murphy, C, Cooper, L, Andaleeb, R, Khalique, S, Bawany, S, Ahmed, S, Carmona-Garcia, MC, Fort-Culillas, R, Liñan, R, Zoratto, F, Rizzo, G, Perachino, M, Doonga, K, Gaidano, G, Bruna, R, Patriarca, A, Martinez-Vila, C, Criado, IP, Giusti, R, Mazzoni, F, Antonuzzo, L, Santoro, A, Parisi, A, Queirolo, P, Aujayeb, A, Rimassa, L, Diamantis, N, Bertulli, R, Fulgenzi, CAM, D'Alessio, A, Ruiz-Camps, I, Saoudi-Gonzalez, N, Illescas, DG, Medina, I, Fox, L, Gennari, A, Aguilar-Company, J and Pinato, DJ.
SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry
LANCET ONCOLOGY 24(4): 335-346
-
Loehr, A, Hussain, A, Patnaik, A, Bryce, AH, Castellano, D, Font, A, Shapiro, J, Zhang, JS, Sautois, B, Vogelzang, NJ, Chatta, G, Courtney, K, Harzstark, A, Ricci, F, Despain, D, Watkins, S, King, C, Nguyen, M, Simmons, AD, Chowdhury, S and Abida, W.
Emergence of BRCA Reversion Mutations in Patients with Metastatic Castration-resistant Prostate Cancer After Treatment with Rucaparib
European Urology 83(3): 200-209
-
Prat, A, Braso-Maristany, F, Martinez-Saez, O, Sanfeliu, E, Xia, YL, Bellet, M, Galvan, P, Martinez, D, Pascual, T, Marin-Aguilera, M, Rodriguez, A, Chic, N, Adamo, B, Pare, L, Vidal, M, Margeli, M, Ballana, E, Gomez-Rey, M, Oliveira, M, Felip, E, Matito, J, Sanchez-Bayona, R, Sunol, A, Saura, C, Ciruelos, E, Tolosa, P, Munoz, M, Gonzalez-Farre, B, Villagrasa, P, Parker, JS, Perou, CM and Vivancos, A.
Circulating tumor DNA reveals complex biological features with clinical relevance in metastatic breast cancer
Nature Communications 14(1):
-
Martinez-Bosch, N, Vilarino, N, Alameda, F, Mojal, S, Arumi-Uria, M, Carrato, C, Aldecoa, I, Ribalta, T, Vidal, N, Bellosillo, B, Menendez, S, Del Barco, S, Gallego, O, Pineda, E, Lopez-Martos, R, Hernandez, A, Mesia, C, Esteve-Codina, A, de la Iglesia, N, Balana, C, Martinez-Garcia, M and Navarro, P.
Gal-1 Expression Analysis in the GLIOCAT Multicenter Study: Role as a Prognostic Factor and an Immune-Suppressive Biomarker
Cells 12(6):
-
Fernandez, SE, Sun, C, Sole-Blanch, C, Boada, A, Martinez-Cardus, A and Manzano, JL.
Immunotherapy Resumption/Rechallenge in Melanoma Patients after Toxicity: Do We Have Another Chance?
Pharmaceutics 15(3):
-
Makker, V, Aghajanian, C, Cohn, AL, Romeo, M, Bratos, R, Brose, MS, Messing, M, Dutta, L, Dutcus, CE, Huang, J, Schmidt, EV, Orlowski, R and Taylor, MH.
A Phase Ib/II Study of Lenvatinib and Pembrolizumab in Advanced Endometrial Carcinoma (Study 111/KEYNOTE-146): Long-Term Efficacy and Safety Update
JOURNAL OF CLINICAL ONCOLOGY 41(5): 974
-
Gutierrez-Chamorro, L, Felip, E, Bernat-Peguera, A, Ezeonwumelu, IJ, Teruel, I, Martinez-Cardus, A, Clotet, B, Riveira-Munoz, E, Romeo, M, Margeli, M and Ballana, E.
SAMHD1 expression modulates innate immune activation and correlates with ovarian cancer prognosis
Frontiers in Immunology 14:
-
Harrington, KJ, Burtness, B, Greil, R, Soulieres, D, Tahara, M, de Castro, G, Psyrri, A, Brana, I, Baste, N, Neupane, P, Bratland, A, Fuereder, T, Hughes, BGM, Mesia, R, Ngamphaiboon, N, Rordorf, T, Ishak, WZW, Lin, JX, Gumuscu, B, Swaby, RF and Rischin, D.
Pembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE-048 Study
JOURNAL OF CLINICAL ONCOLOGY 41(4): 790
-
Mulet-Margalef, N, Linares, J, Badia-Ramentol, J, Jimeno, M, Monte, CS, Mozo, JLM and Calon, A.
Challenges and Therapeutic Opportunities in the dMMR/MSI-H Colorectal Cancer Landscape
Cancers 15(4):
-
de Luna, CJ, Fernandez, E, Mesia, R and Clopes, A.
Clinical practice guidelines for the optimization of hemato-oncological care: the ICOPraxis
CLINICAL & TRANSLATIONAL ONCOLOGY 25(2): 555-559
-
Rodriguez-Vida, A, Maroto, P, Font, A, Martin, C, Mellado, B, Corbera, A, Orrillo, M, Reig, O, Querol, R, Rios-Hoyo, A, Cano, L, Alonso, J, Martinez, G, Galtes, S, Taus, A, Martinez-Garcia, M, Juanpere, N, Juan, O and Bellmunt, J.
Safety and efficacy of avelumab plus carboplatin in patients with metastatic castration-resistant prostate cancer in an open-label Phase Ib study
British Journal of Cancer 128(1): 21-29
-
Vidal, J, Fernández-Rodríguez, MC, Casadevall, D, García-Alfonso, P, Páez, D, Guix, M, Alonso, V, Cano, MT, Santos, C, Durán, G, Elez, E, Manzano, JL, Garcia-Carbonero, R, Ferreiro, R, Losa, F, Pineda, E, Sastre, J, Rivera, F, Bellosillo, B, Tabernero, J, Aranda, E, Salazar, R and Montagut, C.
Liquid Biopsy Detects Early Molecular Response and Predicts Benefit to First-Line Chemotherapy plus Cetuximab in Metastatic Colorectal Cancer: PLATFORM-B Study
Clinical Cancer Research 29(2): 379-388
-
Capote, S, Domenech, M, Valdivieso, L, Tuset, V, Sanchez, M, Carballas, E, Teruel, I, Durany, D, Moragas, G, Molina, C, Lleberia, J, Martinez-Roman, S and Romeo, M.
Small Cell Carcinoma of the Vagina: First Systematic Review of Case Reports and Proposal of a Management Algorithm
Journal of Lower Genital Tract Disease 27(1): 56-67
-
Pineda, E, Domenech, M, Hernandez, A, Comas, S and Balana, C.
Recurrent Glioblastoma: Ongoing Clinical Challenges and Future Prospects
OncoTargets and Therapy 16: 71-86
-
Hernandez, A, Boigues, M, Felip, E, Cucurull, M, Notario, L, Pous, A, Torres, P, Benitez, M, Rodriguez, M, Quirant, B, Romeo, M, Fuster, D and Moran, T.
Immune Response and Effects of COVID-19 Vaccination in Patients with Lung Cancer-COVID Lung Vaccine Study
Cancers 15(1):
-
Ezeonwumelu, IJ, Garcia-Vidal, E, Riveira-Munoz, E, Felip, E, Gutierrez-Chamorro, L, Calba, I, Massanella, M, Sirera, G, Clotet, B, Ballana, E and Badia, R.
Pharmacological Inhibition of IKK to Tackle Latency and Hyperinflammation in Chronic HIV-1 Infection
International Journal of Molecular Sciences 23(23):
-
Cortellini, A, Aguilar-Company, J, Salazar, R, Bower, M, Sita-Lumsden, A, Plaja, A, Lee, AJX, Bertuzzi, A, Tondini, C, Diamantis, N, Martinez-Vila, C, Prat, A, Apthorp, E, Gennari, A and Pinato, DJ.
Natural immunity to SARS-CoV-2 and breakthrough infections in vaccinated and unvaccinated patients with cancer
British Journal of Cancer 127(10): 1787-1792
-
Hitt, R, Mesia, R, Lozano, A, Docampo, LI, Grau, JJ, Taberna, M, Rubio-Casadevall, J, Martinez-Trufero, J, Morillo, ED, Giron, CG, Estevez, SV, Cirauqui, B and Cruz-Hernandez, JJ.
Randomized phase 3 noninferiority trial of radiotherapy and cisplatin vs radiotherapy and cetuximab after docetaxel-cisplatin-fluorouracil induction chemotherapy in patients with locally advanced unresectable head and neck cancer
Oral Oncology 134:
-
Layos, L, Martinez-Balibrea, E and de Porras, VR.
Curcumin: A Novel Way to Improve Quality of Life for Colorectal Cancer Patients?
International Journal of Molecular Sciences 23(22):
-
Yoshida, R, Saigi, M, Tani, T, Springer, BF, Shibata, H, Kitajima, S, Mahadevan, NR, Campisi, M, Kim, W, Kobayashi, Y, Thai, TC, Haratani, K, Yamamoto, Y, Sundararaman, SK, Knelson, EH, Vajdi, A, Canadas, I, Uppaluri, R, Paweletz, CP, Miret, JJ, Lizotte, PH, Gokhale, PC, Janne, PA and Barbie, DA.
MET-Induced CD73 Restrains STING-Mediated Immunogenicity of EGFR-Mutant Lung Cancer
Cancer Research 82(21): 4079-4092
-
Climent, MA, Font, A, Duran, I, Puente, J, Mendez-Vidal, MJ, Saez, MI, Lobera, CS, Arija, JAA, Gonzalez-Del-Alba, A, Sanchez-Hernandez, A, Fita, MJJ, Esteban, E, Alonso-Gordoa, T, Gonzalez, BM, Maroto, P, Lazaro-Quintela, M, Cassinello-Espinosa, J, Perez-Valderrama, B, Garcias, C and Castellano, D.
A phase II randomised trial of abiraterone acetate plus prednisone in combination with docetaxel or docetaxel plus prednisone after disease progression to abiraterone acetate plus prednisone in patients with metastatic castration-resistant prostate cancer: The ABIDO-SOGUG trial
European Journal of Cancer 175: 110-119
-
Prat, A, Paz-Ares, L, Juan, M, Felip, E, Garralda, E, Gonzalez, B, Arance, A, Martin-Liberal, J, Gavila, J, Lopez-Gonzalez, A, Cejalvo, JM, Izarzugaza, Y, Amillano, K, Corbacho, JG, Saura, C, Racca, F, Hierro, C, Sanfeliu, E, Gonzalez, X, Canes, J, Villacampa, G, Salvador, F, Pascual, T, Mesia, R, Cervantes, A and Tabernero, J.
SOLTI-1904 ACROPOLI TRIAL: efficacy of spartalizumab monotherapy across tumor-types expressing high levels of PD1 mRNA
Future Oncology 18(34): 3791-3800
-
Font, A, Domenech, M, Buisan, O, Lopez, H, Gonzalez, A, Etxaniz, O, Matas, M, Elias, X, Gomez, M, Figols, M, Horneros, J, Pardo, JC, Notario, L, de Porras, VR, Perez, I, Areal, J and Esteve, A.
Nomogram based on baseline clinicopathological characteristics for predicting bladder cancer-specific survival to neoadjuvant chemotherapy in muscle-invasive bladder cancer
World Journal of Urology 40(11): 2627-2634
-
Alemany, A, Perez-Zsolt, D, Raich-Regue, D, Munoz-Basagoiti, J, Ouchi, D, Laporte-Villar, C, Baro, B, Henriquez, N, Prat, N, Gianinetto, MO, Gutierrez, MV, Sanchez-Paniagua, MG, Henriquez, NL, Vicente, JM, Ara, J, Rodriguez-Arias, MA, Puig, J, Blanco, I, Lopez, CC, Hernandez, A, Bordoy, AE, Redondo, CE, Soler, VG, Gimenez, M, Blanc, V, Leon, R, Gispert, J, Clotet, B, Izquierdo-Useros, N and Mitja, O.
Cetylpyridinium Chloride Mouthwash to Reduce Shedding of Infectious SARS-CoV-2: A Double-Blind Randomized Clinical Trial
Journal of Dental Research 101(12): 1450-1456
-
Jimenez, N, Reig, O, Marin-Aguilera, M, Aversa, C, Ferrer-Mileo, L, Font, A, Rodriguez-Vida, A, Climent, MA, Cros, S, Chirivella, I, Domenech, M, Figols, M, Gonzalez-Billalabeitia, E, Peralta, DJ, Rodriguez-Carunchio, L, Garcia-Esteve, S, de Herreros, MG, Ribal, MJ, Prat, A and Mellado, B.
Transcriptional Profile Associated with Clinical Outcomes in Metastatic Hormone-Sensitive Prostate Cancer Treated with Androgen Deprivation and Docetaxel
Cancers 14(19):
-
Gonzalez-Barrallo, I, Rubio, VEC, Medina, J, Espana, S, Mujika, K, Majem, M, Aguado, C, Suarez, MAC, Palacio, I, Osterloh, L, Martinez-Fernandez, A and Garcia-Castano, A.
Safety of combining dabrafenib plus trametinib in elderly BRAF V600 mutation-positive advanced melanoma patients: real-world data analysis of Spanish patients (ELDERLYMEL)
Melanoma Research 32(5): 343-352
-
Porras, VRD, Pardo, JC, Etxaniz, O and Font, A.
Neoadjuvant therapy for muscle-invasive bladder cancer: Current clinical scenario, future perspectives, and unsolved questions
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 178:
-
Pascual-Miguel, I, Mariscal-Martinez, A, Sola-Suarez, M, Castella-Fernandez, E, Luna-Tomas, MA, Lopez, JN, Aulina, LB, Cirauqui, BC, Gutierrez, MR, Ribas, J, Corchon, JG, Edo, NR and Julian-Ibanez, JF.
feasible and accurate way to locate breast microcalcifications: Giving Snoll a chance
Clinica e Investigacion en Ginecologia y Obstetricia 49(4):
-
Trigo, J, Garcia-Cosio, M, Garcia-Castano, A, Goma, M, Mesia-Nin, R, Ruiz-Bravo, E, Soria-Rivas, A, Castillo, P, Brana-Garcia, I and Alberola-Ferranti, M.
Recommendations for the use of biomarkers for head and neck cancer, including salivary gland tumours: a consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology
CLINICAL & TRANSLATIONAL ONCOLOGY 24(10): 1890-1902
-
Ezeonwumelu, IJ, Garcia-Vidal, E, Felip, E, Puertas, MC, Oriol-Tordera, B, Gutierrez-Chamorro, L, Gohr, A, Ruiz-Riol, M, Massanella, M, Clotet, B, Martinez-Picado, J, Badia, R, Riveira-Munoz, E and Ballana, E.
IRF7 expression correlates with HIV latency reversal upon specific blockade of immune activation
Frontiers in Immunology 13:
-
Romeo, M, Gil-Martin, M, Gaba, L, Teruel, I, Taus, A, Fina, C, Masvidal, M, Murata, P, Fernandez-Plana, J, Martinez, A, Perez, C, Garcia, Y, Rodriguez, V, Cros, S, Parera, M, Zanui, M, Catot, S, Pardo, B, Plaja, A, Esteve, A and Barretina-Ginesta, MP.
Multicenter Real-World Data of Subsequent Chemotherapy after Progression to PARP Inhibitors in a Maintenance Relapse Setting
Cancers 14(18):
-
Odeny, TA, Lurain, K, Strauss, J, Fling, SP, Sharon, E, Wright, A, Martinez-Picado, J, Moran, T, Gulley, JL, Gonzalez-Cao, M, Uldrick, TS, Yarchoan, R and Ramaswami, R.
Effect of CD4+T cell count on treatment-emergent adverse events among patients with and without HIV receiving immunotherapy for advanced cancer
Journal for ImmunoTherapy of Cancer 10(9):
-
Saigi, M, Carcereny, E, Moran, T, Cucurull, M, Hernandez, A, Pros, E, Sanchez-Cespedes, M, Domenech, M and Martinez-Cardus, A.
Biological and clinical perspectives of the actionable gene fusions and amplifications involving tyrosine kinase receptors in lung cancer
Cancer Treatment Reviews 109:
-
Hernandez, A, Munoz-Marmol, AM, Esteve-Codina, A, Alameda, F, Carrato, C, Pineda, E, Arpi-Llucia, O, Martinez-Garcia, M, Mallo, M, Gut, M, del Barco, S, Gallego, O, Dabad, M, Mesia, C, Bellosillo, B, Domenech, M, Vidal, N, Aldecoa, I, de la Iglesia, N and Balana, C.
In silico validation of RNA-Seq results can identify gene fusions with oncogenic potential in glioblastoma
Scientific Reports 12(1):
-
Szabados, B, Kockx, M, Assaf, ZJ, van Dam, PJ, Rodriguez-Vida, A, Duran, I, Crabb, SJ, van der Heijden, MS, Pous, AF, Gravis, G, Herranz, UA, Protheroe, A, Ravaud, A, Maillet, D, Mendez, MJ, Suarez, C, Linch, M, Prendergast, A, Tyson, C, Stanoeva, D, Daelemans, S, Rombouts, M, Mariathasan, S, Tea, JS, Mousa, K, Sharma, S, Aleshin, A, Banchereau, R, Castellano, D and Powles, T.
Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the Bladder
European Urology 82(2): 212-222
-
Marin-Jimenez, JA, Oliva, M, Martin, PP, Cabezas-Camarero, S, Serrahima, MP, Masedo, GV, Borbalas, AL, Martin, MNC, Esteve, A, Moreno, MCI, Altamis, EV, Hortiguela, LA, Sanz, MT, Perez-Segura, P and Mesia, R.
Paclitaxel Plus Cetuximab as Induction Chemotherapy for Patients With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma Unfit for Cisplatin-Based Chemotherapy
Frontiers in Oncology 12:
-
Cortellini, A, Gennari, A, Pommeret, F, Patel, G, Newsom-Davis, T, Bertuzzi, A, Viladot, M, Aguilar-Company, J, Mirallas, O, Felip, E, Lee, AJX, Dalla Pria, A, Sharkey, R, Brunet, J, Carmona-Garcia, M, Chester, J, Mukherjee, U, Scotti, L, Dolly, S, Sita-Lumsden, A, Ferrante, D, Van Hemelrijck, M, Moss, C, Russell, B, Segui, E, Biello, F, Krengli, M, Marco-Hernandez, J, Gaidano, G, Patriarca, A, Bruna, R, Roldan, E, Fox, L, Pous, A, Griscelli, F, Salazar, R, Martinez-Vila, C, Sureda, A, Loizidou, A, Maluquer, C, Stoclin, A, Iglesias, M, Pedrazzoli, P, Rizzo, G, Santoro, A, Rimassa, L, Rossi, S, Harbeck, N, de Torre, AS, Vincenzi, B, Libertini, M, Provenzano, S, Generali, D, Grisanti, S, Berardi, R, Tucci, M, Mazzoni, F, Lambertini, M, Tagliamento, M, Parisi, A, Zoratto, F, Queirolo, P, Giusti, R, Guida, A, Zambelli, A, Tondini, C, Maconi, A, Betti, M, Colomba, E, Diamantis, N, Sinclair, A, Bower, M, Ruiz-Camps, I and Pinato, DJ.
COVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid Registry
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE 114(7): 979-987
-
Pinato, DJ, Aguilar-Company, J, Ferrante, D, Hanbury, G, Bower, M, Salazar, R, Mirallas, O, Sureda, A, Plaja, A, Cucurull, M, Mesia, R, Townsend, S, Jackson, A, Dalla Pria, A, Newsom-Davis, T, Handford, J, Sita-Lumsden, A, Apthorp, E, Vincenzi, B, Bertuzzi, A, Brunet, J, Lambertini, M, Maluquer, C, Pedrazzoli, P, Biello, F, Sinclair, A, Bawany, S, Khalique, S, Rossi, S, Rogers, L, Murphy, C, Belessiotis, K, Carmona-Garcia, MC, Sharkey, R, Garcia-Illescas, D, Rizzo, G, Perachino, M, Saoudi-Gonzalez, N, Doonga, K, Fox, L, Roldan, E, Gaidano, G, Ruiz-Camps, I, Bruna, R, Patriarca, A, Martinez-Vila, C, Cantini, L, Zambelli, A, Giusti, R, Mazzoni, F, Caliman, E, Santoro, A, Grosso, F, Parisi, A, Queirolo, P, Aujayeb, A, Rimassa, L, Prat, A, Tucci, M, Libertini, M, Grisanti, S, Mukherjee, U, Diamantis, N, Fusco, V, Generali, D, Provenzano, S, Gennari, A, Tabernero, J and Cortellini, A.
Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study
LANCET ONCOLOGY 23(7): 865-875
-
Ferrando-Diez, A, Felip, E, Pous, A, Sirven, MB and Margeli, M.
Targeted Therapeutic Options and Future Perspectives for HER2-Positive Breast Cancer
Cancers 14(14):
-
Martin, M, Zielinski, C, Ruiz-Borrego, M, Carrasco, E, Ciruelos, EM, Munoz, M, Bermejo, B, Margeli, M, Csoszi, T, Anton, A, Turner, N, Casas, MI, Morales, S, Alba, E, Calvo, L, De La Haba-Rodriguez, J, Ramos, M, Murillo, L, Santaballa, A, Alonso-Romero, JL, Sanchez-Rovira, P, Corsaro, M, Huang, X, Thallinger, C, Kahan, Z and Gil-Gil, M.
Overall survival with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer in the PEARL study
European Journal of Cancer 168: 12-24
-
Camidge, DR, Moran, T, Demedts, I, Grosch, H, Mileham, K, Molina, J, Juan-Vidal, O, Bepler, G, Goldman, JW, Park, K, Wallin, J, Wijayawardana, SR, Wang, XJA, Wacheck, V and Smit, E.
A Randomized, Open-Label Phase II Study Evaluating Emibetuzumab Plus Erlotinib and Emibetuzumab Monotherapy in MET Immunohistochemistry Positive NSCLC Patients with Acquired Resistance to Erlotinib
Clinical Lung Cancer 23(4): 300-310
-
Balana, C, Castaner, S, Carrato, C, Moran, T, Lopez-Paradis, A, Domenech, M, Hernandez, A and Puig, J.
Preoperative Diagnosis and Molecular Characterization of Gliomas With Liquid Biopsy and Radiogenomics
Frontiers in Neurology 13:
-
Pons, L, Hernandez-Leon, L, Altaleb, A, Ussene, E, Iglesias, R, Castillo, A, Rodriguez-Martinez, P, Castella, E, Quiroga, V, Felip, E, Cirauqui, B, Margeli, M and Fernandez, PL.
Conventional and digital Ki67 evaluation and their correlation with molecular prognosis and morphological parameters in luminal breast cancer
Scientific Reports 12(1):
-
Arribas, L, Sabate-Llobera, A, Domingo, MC, Taberna, M, Sospedra, M, Martin, L, Gonzalez-Tampan, AR, Pallares, N, Mesia, R and Baracos, VE.
Assessing dynamic change in muscle during treatment of patients with cancer: Precision testing standards
Clinical Nutrition 41(5): 1059-1065
-
Losa, F, Fernandez, I, Etxaniz, O, Gimenez, A, Gomila, P, Iglesias, L, Longo, F, Nogales, E, Sanchez, A and Soler, G.
SEOM-GECOD clinical guideline for unknown primary cancer (2021)
CLINICAL & TRANSLATIONAL ONCOLOGY 24(4): 681-692
-
Bernat-Peguera, A, Trigueros, M, Ferrando-Diez, A, Ibanez, C, Bystrup, S, Martinez-Cardus, A, Margeli, M and Martinez-Balibrea, E.
Efficacy of CT-P6 (trastuzumab biosimilar) versus reference trastuzumab in combination with pertuzumab in HER2-positive early-stage breast cancer: Preclinical and real-life clinical data
Breast 62: 1-9
-
Dominguez, AR, Cirauqui, B, Castano, AG, Cabellos, RA, Maseda, AC, Fernandez, BC, Rey, LI, Rubio-Casadevall, J, Arrazubi, V and Mesia, R.
SEOM-TTCC clinical guideline in nasopharynx cancer (2021)
CLINICAL & TRANSLATIONAL ONCOLOGY 24(4): 670-680
-
Panciroli, C, Esteve, A, Munoz-Ferrer, A, Abad, J, Hernandez, JM, Balana, C, Lucente, G, Comas, S and Villa, S.
Prospective pilot study to explore the melatonin level in brain tumor patients undergoing radiotherapy
Sleep and Breathing 26(1): 469-475
-
Guo, TT, Chu, L, Chu, X, Yang, X, Li, YD, Zhou, Y, Xu, DY, Zhang, JM, Wang, SP, Hu, J, Chu, Q, Moran, T, Cho, WCS, Merrell, KW, Rizzo, S, Liu, YF, Ni, JJ and Zhu, ZF.
Brain metastases, patterns of intracranial progression, and the clinical value of upfront cranial radiotherapy in patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors
Translational Lung Cancer Research 11(2): 173-173
-
Ledermann, JA, Zurawski, B, Raspagliesi, F, De Giorgi, U, Arija, JA, Marin, MR, Lisyanskaya, A, Poka, RL, Markowska, J, Cebotaru, C, Herraez, AC, Colombo, N, Kutarska, E, Hall, M, Jacobs, A, Ahrens-Fath, I, Baumeister, H, Zurlo, A and Sehouli, J.
Maintenance therapy of patients with recurrent epithelial ovarian carcinoma with the anti-tumor-associated-mucin-1 antibody gatipotuzumab: results from a double-blind, placebo-controlled, randomized, phase II study
ESMO Open 7(1):
-
Pardo, JC, de Porras, VR, Gil, J, Font, A, Puig-Domingo, M and Jorda, M.
Lipid Metabolism and Epigenetics Crosstalk in Prostate Cancer
Nutrients 14(4):
-
Pardo, JC, Sanhueza, T, de Porras, VR, Etxaniz, O, Rodriguez, H, Martinez-Cardus, A, Grande, E, Castellano, D, Climent, MA, Lobato, T, Estudillo, L, Jorda, M, Carrato, C and Font, A.
Prognostic Impact of CD36 Immunohistochemical Expression in Patients with Muscle-Invasive Bladder Cancer Treated with Cystectomy and Adjuvant Chemotherapy
Journal of Clinical Medicine 11(3):
-
Felip, E, Gutierrez-Chamorro, L, Gomez, M, Garcia-Vidal, E, Romeo, M, Moran, T, Layos, L, Perez-Roca, L, Riveira-Munoz, E, Clotet, B, Fernandez, PL, Mesia, R, Martinez-Cardus, A, Ballana, E and Margeli, M.
Modulation of DNA Damage Response by SAM and HD Domain Containing Deoxynucleoside Triphosphate Triphosphohydrolase (SAMHD1) Determines Prognosis and Treatment Efficacy in Different Solid Tumor Types
Cancers 14(3):
-
Arrazubi, V, Cajaraville, G, Cantero, D, Giralt, J, Mesia, R, Monje, F, Rueda, A, Sistiaga, A, Suarez, J, Mut, A, Comellas, M and Lizan, L.
Defining a Standard Set of Health Outcomes for Patients With Squamous Cell Carcinoma of the Head and Neck in Spain
Frontiers in Oncology 11: 747520-747520
-
Cucurull M, Notario L, Sanchez-Cespedes M, Hierro C, Estival A, Carcereny E and Saigí M.
Targeting KRAS in Lung Cancer Beyond KRAS G12C Inhibitors: The Immune Regulatory Role of KRAS and Novel Therapeutic Strategies.
Frontiers in Oncology 11: 793121-793121
-
Maurits, JSF, van der Zanden, LFM, Diekstra, MHM, Ambert, V, Castellano, D, Garcia-Donas, J, Troyas, RG, Guchelaar, HJ, Jaehde, U, Junker, K, Martinez-Cardus, A, Radu, MT, Rodriguez-Antona, C, Roessler, M, Warren, A, Eiseng, T, Oosterwijk, E, Kiemeneya, LALM and Vermeulen, SH.
Logical Imputation to Optimize Prognostic Risk Classification in Metastatic Renal Cell Cancer
Kidney Cancer 6(3): 169-178
-
Albanell J, Martínez MT, Ramos M, O'Connor M, de la Cruz-Merino L, Santaballa A, Martínez-Jañez N, Moreno F, Fernández I, Alarcón J, Virizuela JA, de la Haba-Rodríguez J, Sánchez-Rovira P, González-Cortijo L, Margelí M, Sánchez-Muñoz A, Antón A, Casas M, Bezares S and Rojo F.
Randomized phase II study of fulvestrant plus palbociclib or placebo in endocrine-sensitive, hormone receptor-positive/HER2-advanced breast cancer: GEICAM/2014-12 (FLIPPER).
European Journal of Cancer 161: 26-37
-
Centeno C, Serra Mitja P, Avila M, Carcereny E, Muñoz-Mármol AM, Moran T, Castellà E, Sanz-Santos J, García Olivé I, Ramirez Serrano JL, Rosell Gratacos A and Andreo García F.
Molecular analysis in cytological samples obtained by endobronchial or oesophageal ultrasound guided needle aspiration in non-small cell lung cancer.
Pulmonology 28(1): 28-33
-
Pinato, DJ, Patel, M, Scotti, L, Colomba, E, Dolly, S, Loizidou, A, Chester, J, Mukherjee, U, Zambelli, A, Dalla Pria, A, Aguilar-Company, J, Bower, M, Salazar, R, Bertuzzi, A, Brunet, J, Lambertini, M, Tagliamento, M, Pous, A, Sita-Lumsden, A, Srikandarajah, K, Colomba, J, Pommeret, F, Segui, E, Generali, D, Grisanti, S, Pedrazzoli, P, Rizzo, G, Libertini, M, Moss, C, Evans, JS, Russell, B, Harbeck, N, Vincenzi, B, Biello, F, Bertulli, R, Ottaviani, D, Linan, R, Rossi, S, Carmona-Garcia, MC, Tondini, C, Fox, L, Baggi, A, Fotia, V, Parisi, A, Porzio, G, Queirolo, P, Cruz, CA, Saoudi-Gonzalez, N, Felip, E, Lloveras, AR, Newsom-Davis, T, Sharkey, R, Roldan, E, Reyes, R, Zoratto, F, Earnshaw, I, Ferrante, D, Marco-Hernandez, J, Ruiz-Camps, I, Gaidano, G, Patriarca, A, Bruna, R, Sureda, A, Martinez-Vila, C, de Torre, AS, Berardi, R, Giusti, R, Mazzoni, F, Guida, A, Rimassa, L, Chiudinelli, L, Franchi, M, Krengli, M, Santoro, A, Prat, A, Tabernero, J, Van Hemelrijck, M, Diamantis, N, Gennari, A and Cortellini, A.
Time-Dependent COVID-19 Mortality in Patients With Cancer An Updated Analysis of the OnCovid Registry
JAMA Oncology 8(1): 114-122
-
Martori, C, Sanchez-Moral, L, Paul, T, Pardo, JC, Font, A, de Porras, VR and Sarrias, MR.
Macrophages as a Therapeutic Target in Metastatic Prostate Cancer: A Way to Overcome Immunotherapy Resistance?
Cancers 14(2):
-
Sant, M, Bernat-Peguera, A, Felip, E and Margeli, M.
Role of ctDNA in Breast Cancer
Cancers 14(2):
-
de Porras, VR, Font, A and Aytes, A.
Chemotherapy in metastatic castration-resistant prostate cancer: Current scenario and future perspectives
Cancer Letters 523: 162-169
-
Plaja, A, Moran, T, Carcereny, E, Saigi, M, Hernandez, A, Cucurull, M and Domenech, M.
Small-Cell Lung Cancer Long-Term Survivor Patients: How to Find a Needle in a Haystack?
International Journal of Molecular Sciences 22(24):
-
Riudavets, M, Bosch-Barrera, J, Cabezon-Gutierrez, L, Tain, PD, Hernandez, A, Alonso, M, Blanco, R, Galvez, E, Insa, A, Mielgo, X, Moran, T, Ponce, S, Roa, D, Sanchez, JM and Majem, M.
Efficacy of nintedanib plus docetaxel in patients with refractory advanced epidermal growth factor receptor mutant lung adenocarcinoma
CLINICAL & TRANSLATIONAL ONCOLOGY 23(12): 2560-2567
-
Hernandez, A, Domenech, M, Munoz-Marmol, AM, Carrato, C and Balana, C.
Glioblastoma: Relationship between Metabolism and Immunosuppressive Microenvironment
Cells 10(12):
-
Font, A, de Porras, VR, Valderrama, BP, Ramirez, JL, Nonell, L, Virizuela, JA, Anido, U, Gonzalez-del-Alba, A, Lainez, N, Llorente, MD, Jimenez, N, Mellado, B, Garcia-Donas, J and Bellmunt, J.
Epithelial-to-Mesenchymal Transition Mediates Resistance to Maintenance Therapy with Vinflunine in Advanced Urothelial Cell Carcinoma
Cancers 13(24):
-
Bossi, P, Trama, A, Bernasconi, A, Grisanti, S, Mohamad, I, Galiana, IL, Ozyar, E, Franco, P, Vecchio, S, Bonomo, P, Cirauqui, BC, El-Sherify, M, Ursino, S, Argiris, A, Pan, J, Wittekindt, C, D'Angelo, E, Costa, L, Buglione, M, Johnson, J, Airoldi, M, Mesia, R, Resteghini, C, Licitra, L and Orlandi, E.
Nasopharyngeal cancer in non-endemic areas: Impact of treatment intensity within a large retrospective multicentre cohort
European Journal of Cancer 159: 194-204
-
Aliagas, E, Alay, A, Martinez-Iniesta, M, Hernandez-Madrigal, M, Cordero, D, Gausachs, M, Pros, E, Saigi, M, Busacca, S, Sharkley, AJ, Dawson, A, Palmero, R, Ruffinelli, JC, Padrones, S, Aso, S, Escobar, I, Ramos, R, Llatjos, R, Vidal, A, Dorca, E, Varela, M, Sanchez-Cespedes, M, Fennell, D, Munoz-Pinedo, C, Villanueva, A, Sole, X and Nadal, E.
Efficacy of CDK4/6 inhibitors in preclinical models of malignant pleural mesothelioma
British Journal of Cancer 125(10): 1365-1376
-
Domenech, M, Hernandez, A, Plaja, A, Martinez-Balibrea, E and Balana, C.
Hypoxia: The Cornerstone of Glioblastoma
International Journal of Molecular Sciences 22(22):
-
Arribas, L, Sabate-Llobera, A, Taberna, M, Pallares, N, Marin, AN, Virgili, N, Hurtos, L, Peiro, I, Vilajosana, E, Lozano, A, Baracos, V and Mesia, R.
Adequacy of nutritional support using computed tomography (CT) in patients with head and neck cancer (HNC) during chemo-radiotherapy (CRT)
European Journal of Clinical Nutrition 75(10): 1515-1519
-
Kahan, Z, Gil-Gil, M, Ruiz-Borrego, M, Carrasco, E, Ciruelos, E, Munoz, M, Bermejo, B, Margeli, M, Anton, A, Casas, M, Csoszi, T, Murillo, L, Morales, S, Calvo, L, Lang, I, Alba, E, de la Haba-Rodriguez, J, Ramos, M, Lopez, IA, Gal-Yam, E, Garcia-Palomo, A, Alvarez, E, Gonzalez-Santiago, S, Rodriguez, CA, Servitja, S, Corsaro, M, Rodrigalvarez, G, Zielinski, C and Martin, M.
Original Research Health-related quality of life with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive metastatic breast cancer: Patient-reported outcomes in the PEARL study
European Journal of Cancer 156: 70-82
-
Lozano, A, Marruecos, J, Rubio, J, Farre, N, Gomez-Millan, J, Morera, R, Planas, I, Lanzuela, M, Vazquez-Masedo, MG, Cascallar, L, Giralt, J, Escames, G, Valenti, V, Grima, P, Bosser, R, Tarrago, C and Mesia, R.
Randomized placebo-controlled phase II trial of high-dose melatonin mucoadhesive oral gel for the prevention and treatment of oral mucositis in patients with head and neck cancer undergoing radiation therapy concurrent with systemic treatment
CLINICAL & TRANSLATIONAL ONCOLOGY 23(9): 1801-1810
-
Gutierrez-Chamorro, L, Felip, E, Ezeonwumelu, IJ, Margeli, M and Ballana, E.
Cyclin-dependent Kinases as Emerging Targets for Developing Novel Antiviral Therapeutics
Trends in Microbiology 29(9): 836-848
-
Hartkopf, AD, Brucker, SY, Taran, FA, Harbeck, N, von Au, A, Naume, B, Pierga, JY, Hoffmann, O, Beckmann, MW, Ryden, L, Fehm, T, Aft, R, Sola, M, Walter, V, Rack, B, Schuetz, F, Borgen, E, Ta, MH, Bittner, AK, Fasching, PA, Ferno, M, Krawczyk, N, Weilbaecher, K, Margeli, M, Hahn, M, Jueckstock, J, Domschke, C, Bidard, FC, Kasimir-Bauer, S, Schoenfisch, B, Kurt, AG, Wallwiener, M, Gebauer, G, Klein, CA, Wallwiener, D, Janni, W and Pantel, K.
Disseminated tumour cells from the bone marrow of early breast cancer patients: Results from an international pooled analysis
European Journal of Cancer 154: 128-137
-
Garrido, P, Paz-Ares, L, Majem, M, Moran, T, Trigo, JM, Bosch-Barrera, J, Garcia-Campelo, R, Gonzalez-Larriba, JL, Sanchez-Torres, JM, Isla, D, Vinolas, N, Camps, C, Insa, A, Juan, O, Massuti, B, Paredes, A, Artal, A, Lopez-Brea, M, Palacios, J and Felip, E.
LungBEAM: A prospective multicenter study to monitor stage IV NSCLC patients with EGFR mutations using BEAMing technology
Cancer Medicine 10(17): 5878-5888
-
Domènech M, Muñoz Marmol AM, Mate JL, Estival A, Moran T, Cucurull M, Saigi M, Hernandez A, Sanz C, Hernandez-Gallego A, Urbizu A, Martinez-Cardus A, Bernat A and Carcereny E.
Correlation between PD-L1 expression and MET gene amplification in patients with advanced non-small cell lung cancer and no other actionable oncogenic driver.
Oncotarget 12(18): 1802-1810
-
Gutierrez, L, Royuela, A, Carcereny, E, Lopez-Castro, R, Rodriguez-Abreu, D, Massuti, B, Gonzalez-Larriba, JL, Garcia-Campelo, R, Bosch-Barrera, J, Guirado, M, Camps, C, Domine, M, Bernabe, R, Casal, J, Oramas, J, Ortega, AL, Sala, MA, Padilla, A, Aguiar, D, Juan-Vidal, O, Blanco, R, del Barco, E, Martinez-Banaclocha, N, Benitez, G, de Vega, B, Hernandez, A, Saigi, M, Franco, F and Provencio, M.
Prognostic model of long-term advanced stage (IIIB-IV) EGFR mutated non-small cell lung cancer (NSCLC) survivors using real-life data
BMC Cancer 21(1): 977-977
-
Martinez-Trufero, J, Borbalas, AL, Bernad, IP, Sanz, MT, Izquierdo, EO, Cirauqui, BC, Rubio-Casadevall, J, Serrahima, MP, Ortega, JMP, Toledano, IP, Caballero, J, Querol, JM, Docampo, LI, Sorrosal, JL, Adansa, JC and Nin, RM.
Sequential chemotherapy regimen of induction with panitumumab and paclitaxel followed by radiotherapy and panitumumab in patients with locally advanced head and neck cancer unfit for platinum derivatives. The phase II, PANTERA/TTCC-2010-06 study
CLINICAL & TRANSLATIONAL ONCOLOGY 23(8): 1666-1677
-
Bosch-Barrera, J, Verdura, S, Ruffinelli, JC, Carcereny, E, Sais, E, Cuyas, E, Palmero, R, Lopez-Bonet, E, Hernandez-Martinez, A, Oliveras, G, Buxo, M, Izquierdo, A, Moran, T, Nadal, E and Menendez, JA.
Silibinin Suppresses Tumor Cell-Intrinsic Resistance to Nintedanib and Enhances Its Clinical Activity in Lung Cancer
Cancers 13(16):
-
Ruiz de Porras V, Layos L and Martínez-Balibrea E.
Curcumin: A therapeutic strategy for colorectal cancer?
Seminars in Cancer Biology 73: 321-330
-
Romero, OA, Vilarrubi, A, Alburquerque-Bejar, JJ, Gomez, A, Andrades, A, Trastulli, D, Pros, E, Setien, F, Verdura, S, Farre, L, Martin-Tejera, JF, Llabata, P, Oaknin, A, Saigi, M, Piulats, JM, Matias-Guiu, X, Medina, PP, Vidal, A, Villanueva, A and Sanchez-Cespedes, M.
SMARCA4 deficient tumours are vulnerable to KDM6A/UTX and KDM6B/JMJD3 blockade
Nature Communications 12(1): 4319-4319
-
Schoffski, P, Toulmonde, M, Estival, A, Marquina, G, Dudzisz-Sledz, M, Brahmi, M, Steeghs, N, Karavasilis, V, de Haan, J, Wozniak, A, Cousin, S, Domenech, M, Bovee, JVMG, Charon-Barra, C, Marreaud, S, Litiere, S, De Meulemeester, L, Olungu, C and Gelderblom, H.
Randomised phase 2 study comparing the efficacy and safety of the oral tyrosine kinase inhibitor nintedanib with single agent ifosfamide in patients with advanced, inoperable, metastatic soft tissue sarcoma after failure of first-line chemotherapy: EORTC-1506-STBSG "ANITA"
European Journal of Cancer 152: 26-40
-
Provencio, M, Gallego, JMM, Calles, A, Antonanzas, M, Pangua, C, Rubio, XM, Nadal, E, Castro, RL, Lopez-Martin, A, Del Barco, E, Domine, M, Franco, F, Diz, P, Sandoval, C, Girona, ES, Sullivan, I, Sala, MA, Ledo, GG, Cucurull, M, Mosquera, J, Martinez, M, Chara, LE, Arriola, E, Herrera, BE, Jarabo, JR, Alvarez, RA, Baena, J and Cao, MG.
Lung cancer patients with COVID-19 in Spain: GRAVID study
Lung Cancer 157: 109-115
-
Zhang, XY, Tian, D, Chen, Y, Chen, C, He, LN, Zhou, YX, Li, HF, Lin, Z, Chen, T, Wang, YH, Russo, A, Nadal, E, Passiglia, F, Soo, RA, Watanabe, S, Moran, T, Oh, IJ, Fu, S, Hong, SD and Zhang, L.
Association of hepatitis B virus infection status with outcomes of non-small cell lung cancer patients undergoing anti-PD-1/PD-L1 therapy
Translational Lung Cancer Research 10(7): 3191-3202
-
Arribas, L, Plana, M, Taberna, M, Sospedra, M, Vilarino, N, Oliva, M, Pallares, N, Tampan, ARG, Del Rio, LM, Mesia, R and Baracos, V.
Predictive Value of Skeletal Muscle Mass in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Patients Treated With Immune Checkpoint Inhibitors
Frontiers in Oncology 11:
-
Munoz-Guardiola, P, Casas, J, Megias-Roda, E, Sole, S, Perez-Montoyo, H, Yeste-Velasco, M, Erazo, T, Dieguez-Martinez, N, Espinosa-Gil, S, Munoz-Pinedo, C, Yoldi, G, Abad, JL, Segura, MF, Moran, T, Romeo, M, Bosch-Barrera, J, Oaknin, A, Alfon, J, Domenech, C, Fabrias, G, Velasco, G and Lizcano, JM.
The anti-cancer drug ABTL0812 induces ER stress-mediated cytotoxic autophagy by increasing dihydroceramide levels in cancer cells
Autophagy 17(6): 1349-1366
-
Franco, F, Carcereny, E, Guirado, M, Ortega, AL, Lopez-Castro, R, Rodriguez-Abreu, D, Garcia-Campelo, R, del Barco, E, Juan, O, Aparisi, F, Gonzalez-Larriba, JL, Domine, M, Trigo, JM, Cobo, M, Cerezo, S, Calzas, J, Massuti, B, Bosch-Barrera, J, Coves, PG, Domenech, M and Provencio, M.
Epidemiology, treatment, and survival in small cell lung cancer in Spain: Data from the Thoracic Tumor Registry
PLoS ONE 16(6):
-
Pinato, DJ, Scotti, L, Gennari, A, Colomba-Blameble, E, Dolly, S, Loizidou, A, Chester, J, Mukherjee, U, Zambelli, A, Aguilar-Company, J, Bower, M, Galazi, M, Salazar, R, Bertuzzi, A, Brunet, J, Mesia, R, Sita-Lumsden, A, Colomba, J, Pommeret, F, Segui, E, Biello, F, Generali, D, Grisanti, S, Rizzo, G, Libertini, M, Moss, C, Evans, JS, Russell, B, Wuerstlein, R, Vincenzi, B, Bertulli, R, Ottaviani, D, Linan, R, Marrari, A, Carmona-Garcia, MC, Sng, CCT, Tondini, C, Mirallas, O, Tovazzi, V, Fotia, V, Cruz, CA, Saoudi-Gonzalez, N, Felip, E, Lloveras, AR, Lee, AJX, Newsom-Davis, T, Sharkey, R, Chung, C, Garcia-Illescas, D, Reyes, R, Wong, YNS, Ferrante, D, Marco-Hernandez, J, Ruiz-Camps, I, Gaidano, G, Patriarca, A, Sureda, A, Martinez-Vila, C, de Torre, AS, Rimassa, L, Chiudinelli, L, Franchi, M, Krengli, M, Santoro, A, Prat, A, Tabernero, J, Hemelrijck, MV, Diamantis, N and Cortellini, A.
Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study
European Journal of Cancer 150: 190-202
-
de Porras, VR, Wang, XC, Palomero, L, Marin-Aguilera, M, Sole-Blanch, C, Indacochea, A, Jimenez, N, Bystrup, S, Bakht, M, Conteduca, V, Piulats, JM, Buisan, O, Suarez, JF, Pardo, JC, Castro, E, Olmos, D, Beltran, H, Mellado, B, Martinez-Balibrea, E, Font, A and Aytes, A.
Taxane-induced Attenuation of the CXCR2/BCL-2 Axis Sensitizes Prostate Cancer to Platinum-based Treatment
European Urology 79(6): 722-733
-
Szabados, B, Rodriguez-Vida, A, Duran, I, Crabb, SJ, Van der Heijden, MS, Pous, AF, Gravis, G, Herranz, UA, Protheroe, A, Ravaud, A, Maillet, D, Mendez-Vidal, MJ, Suarez, C, Linch, M, Prendergast, A, Tyson, C, Mousa, K, Castellano, D and Powles, T.
Toxicity and Surgical Complication Rates of Neoadjuvant Atezolizumab in Patients with Muscle-invasive Bladder Cancer Undergoing Radical Cystectomy: Updated Safety Results from the ABACUS Trial
European urology oncology 4(3): 456-463
-
Majem M, Manzano JL, Marquez-Rodas I, Mujika K, Muñoz-Couselo E, Pérez-Ruiz E, de la Cruz-Merino L, Espinosa E, Gonzalez-Cao M and Berrocal A.
SEOM clinical guideline for the management of cutaneous melanoma (2020).
CLINICAL & TRANSLATIONAL ONCOLOGY 23(5): 948-960
-
de Porras, VR, Pardo, JC, Notario, L, Etxaniz, O and Font, A.
Immune Checkpoint Inhibitors: A Promising Treatment Option for Metastatic Castration-Resistant Prostate Cancer?
International Journal of Molecular Sciences 22(9):
-
Pascual, T, Oliveira, M, Ciruelos, E, Ezquerra, MB, Saura, C, Gavila, J, Pernas, S, Munoz, M, Vidal, MJ, Vila, MM, Cejalvo, JM, Gonzalez-Farre, B, Espinosa-Bravo, M, Cruz, J, Salvador-Bofill, FJ, Guerra, JA, Barrera, AML, de Dios, MA, Esker, S, Fan, PD, Martinez-Saez, O, Villacampa, G, Pare, L, Ferrero-Cafiero, JM, Villagrasa, P and Prat, A.
SOLTI-1805 TOT-HER3 Study Concept: A Window-of-Opportunity Trial of Patritumab Deruxtecan, a HER3 Directed Antibody Drug Conjugate, in Patients With Early Breast Cancer
Frontiers in Oncology 11: 638482-638482
-
Alemany, M, Domenech, M, Argyriou, AA, Vilarino, N, Majos, C, Naval-Baudin, P, Lucas, A, Palmero, R, Simo, M, Nadal, E and Bruna, J.
Perilesional edema in brain metastases as predictive factor of response to systemic therapy in non-small cell lung cancer patients: a preliminary study
Annals of Translational Medicine 9(8):
-
Pous, A, Izquierdo, C, Cucurull, M, Sanchez, S, Lezcano, C, Domenech, M, Llobera, L, Plaja, A and Moran, T.
Immune-checkpoint inhibitors for lung cancer patients amid the COVID-19 pandemic: a case report of severe meningoencephalitis after switching to an extended-interval higher flat-dose nivolumab regimen
Translational Lung Cancer Research 10(4): 1917-1923
-
Majem, M, Cobo, M, Isla, D, Marquez-Medina, D, Rodriguez-Abreu, D, Casal-Rubio, J, Moran-Bueno, T, Bernabe-Caro, R, Perez-Parente, D, Ruiz-Gracia, P, Arroyo, MM and Paz-Ares, L.
PD-(L)1 Inhibitors as Monotherapy for the First-Line Treatment of Non-Small-Cell Lung Cancer Patients with High PD-L1 Expression: A Network Meta-Analysis
Journal of Clinical Medicine 10(7):
-
Martin, M, Zielinski, C, Ruiz-Borrego, M, Carrasco, E, Turner, N, Ciruelos, EM, Munoz, M, Bermejo, B, Margeli, M, Anton, A, Kahan, Z, Csoszi, T, Casas, MI, Murillo, L, Morales, S, Alba, E, Gal-Yam, E, Guerrero-Zotano, A, Calvo, L, de la Haba-Rodriguez, J, Ramos, M, Alvarez, I, Garcia-Palomo, A, Bartlett, CH, Koehler, M, Caballero, R, Corsaro, M, Huang, X, Garcia-Saenz, JA, Chacon, JI, Swift, C, Thallinger, C and Gil-Gil, M.
Palbociclib in combination with endocrine therapy versus capecitabine in hormonal receptor-positive, human epidermal growth factor 2-negative, aromatase inhibitor-resistant metastatic breast cancer: a phase III randomised controlled trial-PEARL
Annals of Oncology 32(4): 488-499
-
Provencio, M, Terrasa, J, Garrido, P, Campelo, RG, Aparisi, F, Diz, P, Aguiar, D, Garcia-Giron, C, Hidalgo, J, Aguado, C, Gonzalez, JG, Esteban, E, Gomez-Aldavari, L, Moran, T, Juan, O, Chara, LE, Marti, JL, Castro, RL, Ortega, AL, Moreno, EM, Coves, J, Pena, AMS, Bosch-Barrera, J, Gastaldo, AS, Nunez, NF, del Barco, E, Cobo, M, Isla, D, Majem, M, Navarro, F and Calvo, V.
Osimertinib in advanced EGFR-T790M mutation-positive non-small cell lung cancer patients treated within the Special Use Medication Program in Spain: OSIREX-Spanish Lung Cancer Group
BMC Cancer 21(1): 230-230
-
Comas, S, Luguera, E, Molero, J, Balana, C, Estival, A, Castaner, S, Carrato, C, Hostalot, C, Teixidor, P and Villa, S.
Influence of glioblastoma contact with the subventricular zone on survival and recurrence patterns
CLINICAL & TRANSLATIONAL ONCOLOGY 23(3): 554-564
-
Martinez, AM, Rosell, IV, Gomez, AS, Catanese, A, Molina, MP, Suarez, MS, Miguel, IP, Aulina, LB, Gozalvez, CR, Ibanez, JFJ, Martinez, PR, Roman, SM, Vila, MM and Tomas, MAL.
Advantages of preoperative localization and surgical resection of metastatic axillary lymph nodes using magnetic seeds after neoadjuvant chemotherapy in breast cancer
SURGICAL ONCOLOGY-OXFORD 36: 28-33
-
Bernat-Peguera, A, Navarro-Ventura, J, Lorenzo-Sanz, L, da Silva-Diz, V, Bosio, M, Palomero, L, Penin, RM, Sidelnikova, DP, Bermejo, JO, Taberna, M, Vilarino, N, Piulats, JM, Mesia, R, Vinals, JM, Gonzalez-Suarez, E, Capella-Gutierrez, S, Villanueva, A, Vinals, F and Munoz, P.
FGFR Inhibition Overcomes Resistance to EGFR-targeted Therapy in Epithelial-like Cutaneous Carcinoma
Clinical Cancer Research 27(5): 1491-1504
-
Garcia-Alfonso, P, Diaz-Rubio, E, Abad, A, Carrato, A, Massuti, B, Ortiz-Morales, MJ, Mozo, JLM, Munoz, A, Duran, G, Sastre, J, Safont, MJ, Ferreiro, R, Rivera, F, Gonzalez, E, Valladares-Ayerbes, M, Gravalos, C, Alonso-Orduna, V, Vieitez, JM, Yubero, A and Aranda, E.
First-Line Biological Agents Plus Chemotherapy in Older Patients with Metastatic Colorectal Cancer: A Retrospective Pooled Analysis
DRUGS & AGING 38(3): 219-231
-
Provencio, M, Majem, M, Guirado, M, Massuti, B, de Las Penas, R, Ortega, AL, Domine, M, Marse, R, Sala, MA, Paredes, A, Moran, T, Vazquez, S, Coves, J, Larriba, JLG, Sanchez, JM, Vicente, D, Farre, N, Fornos, LF, Zapata, I, Franco, F, Serna-Blasco, R, Romero, A and Isla, D.
Phase II clinical trial with metronomic oral vinorelbine and tri-weekly cisplatin as induction therapy, subsequently concomitant with radiotherapy (RT) in patients with locally advanced, unresectable, non-small cell lung cancer (NSCLC). Analysis of survival and value of ctDNA for patient selection
Lung Cancer 153: 25-34
-
Rivera, F, Izquierdo-Manuel, M, Garcia-Alfonso, P, de Castro, EM, Gallego, J, Limon, ML, Alsina, M, Lopez, L, Galan, M, Falco, E, Manzano, JL, Gonzalez, E, Munoz-Unceta, N, Lopez, C, Aranda, E, Fernandez, E, Jorge, M and Jimenez-Fonseca, P.
Perioperative trastuzumab, capecitabine and oxaliplatin in patients with HER2-positive resectable gastric or gastro-oesophageal junction adenocarcinoma: NEOHX phase II trial
European Journal of Cancer 145: 158-167
-
Domenech, M, Grau, E, Solanes, A, Izquierdo, A, Del Valle, J, Carrato, C, Pineda, M, Duenas, N, Pujol, M, Lazaro, C, Capella, G, Brunet, J and Navarro, M.
Characteristics of Adrenocortical Carcinoma Associated With Lynch Syndrome
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM 106(2): 318-325
-
Esteve-Codina, A, Alameda, F, Carrato, C, Pineda, E, Arpi, O, Martinez-Garcia, M, Mallo, M, Gut, M, Dabad, M, Tortosa, A, Del Barco, S, Capellades, J, Puig, J, Gallego, O, Pujol, T, Oleaga, L, Gil-Gil, M, De Quintana-Schmidt, C, Valduvieco, I, Martinez-Cardus, A, Bellosillo, B, Munoz-Marmol, AM, Esteve, A, Domenech, M, Camins, A, Craven-Bartle, J, Villa, S, Marruecos, J, Domenech, S, de la Iglesia, N and Balana, C.
RNA sequencing and Immunohistochemistry Reveal ZFN7 as a Stronger Marker of Survival than Molecular Subtypes in G-CIMP-negative Glioblastoma
Clinical Cancer Research 27(2): 645-655
-
Falco, A, de Oliveira, TB, Cacicedo, J, Ospina, AV, Ticona, MA, Galindo, H, Pereira, MD, Aguilar-Ponce, JL, Rueda-Dominguez, A, Soria, T, Taberna, M, Iglesias, L, Sowley, T and Mesia, R.
Ibero-American Expert Consensus on Squamous Cell Carcinoma of the Head and Neck Treatment in Patients Unable to Receive Cisplatin: Recommendations for Clinical Practice
Cancer Management and Research 13: 6689-6703
-
Linares-Galiana, I, Berenguer-Frances, MA, Canas-Cortes, R, Pujol-Canadell, M, Comas-Anton, S, Martinez, E, Laplana, M, Perez-Montero, H, Pla-Farnos, MJ, Navarro-Martin, A, Nunez, M, Both, B and Guedea, F.
Changes in peripheral immune cells after intraoperative radiation therapy in low-risk breast cancer
Journal of Radiation Research 62(1): 110-118
-
Oliveira, TB, Mesia, R, Falco, A, Hsieh, JCH, Yokota, T, Saada-Bouzid, E, Schmitz, S, Elicin, O, Giacomelli, L and Bossi, P.
Defining the needs of patients with recurrent and/or metastatic head and neck cancer: An expert opinion
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 157:
-
Gonzalez-Cao, M, Puertolas, T, Riveiro, M, Munoz-Couselo, E, Ortiz, C, Paredes, R, Podzamczer, D, Manzano, JL, Molto, J, Revollo, B, Carrera, C, Mateu, L, Fancelli, S, Espinosa, E, Clotet, B, Martinez-Picado, J, Cerezuela, P, Soria, A, Marquez, I, Mandala, M and Berrocal, A.
Cancer immunotherapy in special challenging populations: recommendations of the Advisory Committee of Spanish Melanoma Group (GEM)
Journal for ImmunoTherapy of Cancer 9(3):
-
Salazar, R, Capdevila, J, Manzano, JL, Pericay, C, Martinez-Villacampa, M, Lopez, C, Losa, F, Safont, MJ, Gomez-Espana, A, Alonso-Orduna, V, Escudero, P, Gallego, J, Garcia-Paredes, B, Palacios, A, Biondo, S, Gravalos, C and Aranda, E.
Phase II randomized trial of capecitabine with bevacizumab and external beam radiation therapy as preoperative treatment for patients with resectable locally advanced rectal adenocarcinoma: long term results
BMC Cancer 20(1): 1164-1164
-
Carrato, C, Alameda, F, Esteve-Codina, A, Pineda, E, Arpi, O, Martinez-Garcia, M, Mallo, M, Gut, M, Lopez-Martos, R, Del Barco, S, Ribalta, T, Capellades, J, Puig, J, Gallego, O, Mesia, C, Munoz-Marmol, AM, Archilla, I, Arumi, M, Blanc, JM, Bellosillo, B, Menendez, S, Esteve, A, Bague, S, Hernandez, A, Craven-Bartle, J, Fuentes, R, Vidal, N, Aldecoa, I, de la Iglesia, N and Balana, C.
Glioblastoma TCGA Mesenchymal and IGS 23 Tumors are Identifiable by IHC and have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy
Clinical Cancer Research 26(24): 6600-6609
-
Molins, JB, Jimenez, JGD, Valderrama, BP, Echaburu, JAV, Hernando-Polo, S, Duran, MAC, Villa-Guzman, JC, Arija, JAA, Ostiategui, ML, Milagro, NL, Gonzalez-del-Alba, A, Gonzalez, BM, Diaz, EG, Gauna, DC, Santasusana, MD, Herranz, UA, Solans, XGD, Perez-Gracia, JL, Vazquez, JP, Morales-Barrera, R and Pous, AF.
Final Overall Survival Analysis of the SOGUG Phase 2 MAJA Study: Maintenance Vinflunine Versus Best Supportive Care After First-Line Chemotherapy in Advanced Urothelial Carcinoma
Clinical Genitourinary Cancer 18(6): 452-460
-
Balana, C, Vaz, MA, Sepulveda, JM, Mesia, C, del Barco, S, Pineda, E, Munoz-Langa, J, Estival, A, de las Penas, R, Fuster, J, Girones, R, Navarro, LM, Gil-Gil, M, Alonso, M, Herrero, A, Peralta, S, Olier, C, Perez-Segura, P, Covela, M, Martinez-Garcia, M, Berrocal, A, Gallego, O, Luque, R, Perez-Martin, FJ, Esteve, A, Munne, N, Domenech, M, Villa, S, Sanz, C and Carrato, C.
A phase II randomized, multicenter, open-label trial of continuing adjuvant temozolomide beyond 6 cycles in patients with glioblastoma (GEINO 14-01)
Neuro-Oncology 22(12): 1851-1861
-
Jimenez, N, Reig, O, Montalbo, R, Mila-Guasch, M, Nadal-Dieste, L, Castellano, G, Lozano, JJ, Victoria, I, Font, A, Rodriguez-Vida, A, Carles, J, Suarez, C, Domenech, M, Sala-Gonzalez, N, Fernandez, PL, Rodriguez-Carunchio, L, Diaz, S, Prat, A, Marin-Aguilera, M and Mellado, B.
Cell Plasticity-Related Phenotypes and Taxanes Resistance in Castration-Resistant Prostate Cancer
Frontiers in Oncology 10: 594023-594023
-
Pinato DJ, Zambelli A, Aguilar-Company J, Bower M, Sng C, Salazar R, Bertuzzi A, Brunet J, Mesia R, Segui E, Biello F, Generali D, Grisanti S, Rizzo G, Libertini M, Maconi A, Harbeck N, Vincenzi B, Bertulli R, Ottaviani D, Carbo A, Bruna R, Benafif S, Marrari A, Wuerstlein R, Carmona-Garcia MC, Chopra N, Tondini C, Mirallas O, Tovazzi V, Betti M, Provenzano S, Fotia V, Cruz CA, Dalla Pria A, D'Avanzo F, Evans JS, Saoudi-Gonzalez N, Felip E, Galazi M, Garcia-Fructuoso I, Lee AJX, Newsom-Davis T, Patriarca A, Garcia-Illescas D, Reyes R, Dileo P, Sharkey R, Wong YNS, Ferrante D, Marco-Hernandez J, Sureda A, Maluquer C, Ruiz-Camps I, Gaidano G, Rimassa L, Chiudinelli L, Izuzquiza M, Cabirta A, Franchi M, Santoro A, Prat A, Tabernero J and Gennari A.
Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients.
Cancer Discovery 10(10): 1465-1474
-
Vila, MM, Berron, SD, Gil-Gil, M, Ochoa-Arnedo, C and Vazquez, RV.
Psychosocial aspects and life project disruption in young women diagnosed with metastatic hormone-sensitive HER2-negative breast cancer
Breast 53: 44-50
-
Peters, S, Danson, S, Hasan, B, Dafni, U, Reinmuth, N, Majem, M, Tournoy, KG, Mark, MT, Pless, M, Cobo, M, Rodriguez-Abreu, D, Falchero, L, Moran, T, Granados, ALO, Monnet, I, Mohorcic, K, Sureda, BM, Betticher, D, Demedts, I, Macias, JA, Cuffe, S, Luciani, A, Sanchez, JG, Curioni-Fontecedro, A, Gautschi, O, Price, G, Coate, L, von Moos, R, Zielinski, C, Provencio, M, Menis, J, Ruepp, B, Pochesci, A, Roschitzki-Voser, H, Besse, B, Rabaglio, M, O'Brien, MER and Stahel, RA.
A Randomized Open-Label Phase III Trial Evaluating the Addition of Denosumab to Standard First-Line Treatment in Advanced NSCLC: The European Thoracic Oncology Platform (ETOP) and European Organisation for Research and Treatment of Cancer (EORTC) SPLENDOUR Trial
Journal of Thoracic Oncology 15(10): 1647-1656
-
Yamamoto, N, Hayashi, H, Planchard, D, Moran, T, Gregorc, V, Dowell, J, Sakai, H, Yoh, K, Nishio, M, Cortot, AB, Benhadji, KA, Soni, N, Huang, J, Makris, L and Cedres, S.
A randomized, phase 2 study of deoxyuridine triphosphatase inhibitor, TAS-114, in combination with S-1 versus S-1 alone in patients with advanced non-small-cell lung cancer
Investigational New Drugs 38(5): 1588-1597
-
Felip, E, Llobera, L, Perez-Mana, C, Quintela, D, Guasch, I, Margeli, M, Teruel, I, Cirauqui, B, Centeno, C, Romeo, M, Ballana, E and Quiroga, V.
New Drugs, Old Toxicities: Pneumonitis Related to Palbociclib - A Case Report
Breast Care 15(5): 548-552
-
Van Cutsem, E, Tempero, MA, Sigal, D, Oh, DY, Fazio, N, Macarulla, T, Hitre, E, Hammel, P, Hendifar, AE, Bates, SE, Li, CP, Hingorani, SR, de la Fouchardiere, C, Kasi, A, Heinemann, V, Maraveyas, A, Bahary, N, Layos, L, Sahai, V, Zheng, L, Lacy, J, Park, JO, Portales, F, Oberstein, P, Wu, W, Chondros, D and Bullock, AJ.
Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma
JOURNAL OF CLINICAL ONCOLOGY 38(27): 3185-3194
-
Remon, J, Nadal, E, Domine, M, Ruffinelli, J, Garcia, Y, Pardo, JC, Lopez, R, Cilleruelo, A, Garcia-Campelo, R, Martin, P, Juan, O, Gonzalez-Larriba, JL, Provencio, M, Olmedo, E, Ponce, S, Cumplido, D, Barenys, C, Majem, M, Massutti, B, Rodriguez-Abreu, D, Porta, R, Sala, MA, Martinez-Kareaga, M, Lianes, P and Reguart, N.
Malignant pleural mesothelioma: Treatment patterns and outcomes from the Spanish Lung Cancer Group
Lung Cancer 147: 83-90
-
Moran, T, Taus, A, Arriola, E, Aguado, C, Domine, M, Rueda, AG, Calles, A, Cedres, S, Vinolas, N, Isla, D, Palmero, R, Sereno, M, Diaz, V, Juan, O, Marse, R, Martorell, PM and Torres, JMS.
Clinical Activity of Afatinib in Patients With Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Spanish Retrospective Multicenter Study
Clinical Lung Cancer 21(5): 428
-
Pardo, JC, de Porras, VR, Plaja, A, Carrato, C, Etxaniz, O, Buisan, O and Font, A.
Moving towards Personalized Medicine in Muscle-Invasive Bladder Cancer: Where Are We Now and Where Are We Going?
International Journal of Molecular Sciences 21(17):
-
Lopez-Plana, A, Fernandez-Nogueira, P, Munoz-Guardiola, P, Sole-Sanchez, S, Megias-Roda, E, Perez-Montoyo, H, Jauregui, P, Yeste-Velasco, M, Gomez-Ferreria, M, Erazo, T, Ametller, E, Recalde-Percaz, L, Moragas-Garcia, N, Noguera-Castells, A, Mancino, M, Moran, T, Nadal, E, Alfon, J, Domenech, C, Gascon, P, Lizcano, JM, Fuster, G and Bragado, P.
The novel proautophagy anticancer drug ABTL0812 potentiates chemotherapy in adenocarcinoma and squamous nonsmall cell lung cancer
International Journal of Cancer 147(4): 1163-1179
-
Mena, M, Frias-Gomez, J, Taberna, M, Quiros, B, Marquez, S, Clavero, O, Baena, A, Lloveras, B, Alejo, M, Leon, X, Garcia, J, Mesia, R, Bermejo, O, Bonfill, T, Aguila, A, Guix, M, Hijano, R, Pavon, MA, Torres, M, Tous, S, Cleries, R and Alemany, L.
Epidemiology of human papillomavirus-related oropharyngeal cancer in a classically low-burden region of southern Europe
Scientific Reports 10(1):
-
Viros Porcuna D, Pollan Guisasola C, Viña Soria C, Cirauqui Cirauqui B, Pardo Muñoz L, Collurá F and Mesia Nin R.
Transoral robotic surgery for squamous cell carcinoma of the oropharynx in a primarily human papillomavirus-negative patient population.
CLINICAL & TRANSLATIONAL ONCOLOGY 22(8): 1303-1311
-
Laquente, B, Macarulla, T, Buges, C, Martin, M, Garcia, C, Pericay, C, Merino, S, Visa, L, Martin, T, Pedraza, M, Carnero, B, Guardeno, R, Verdaguer, H, Mut, A, Vilanova, D and Garcia, A.
Quality of life of patients with metastatic pancreatic adenocarcinoma initiating first-line chemotherapy in routine practice
BMC Palliative Care 19(1): 103-103
-
Vicente-Baz D, Paredes A, Morán T, Massuti B, Reguart N, Álvarez R, Insa A, Juan-Vidal O, Artal Á, Esteban E, García-Campelo R, Ortega-Granados AL, Diz P, González-Larriba JL, Terrasa J, de Las Peñas R, Rodríguez-Abreu D, Callejo Á, Márquez G and Provencio M.
ASTRIS, a large real-world study to evaluate the efficacy of osimertinib in epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer patients: Clinical characteristics and genotyping methods in a Spanish cohort.
Revista Espanola de Patologia 53(3): 140-148
-
Mezquita, L, Jove, M, Nadal, E, Kfoury, M, Moran, T, Ricordel, C, Dhooge, M, Tlemsani, C, Lena, H, Teule, A, Alvarez, JV, Raimbourg, J, Hiret, S, Lacroix, L, Menendez, M, Saldana, J, Brunet, J, Lianes, P, Coupier, I, Auclin, E, Recondo, G, Friboulet, L, Adam, J, Green, E, Planchard, D, Frebourg, T, Capella, G, Rouleau, E, Lazaro, C, Caron, O and Besse, B.
High Prevalence of Somatic Oncogenic Driver Alterations in Patients With NSCLC and Li-Fraumeni Syndrome
Journal of Thoracic Oncology 15(7): 1232-1239
-
Font, A, Domenech, M, Benitez, R, Rava, M, Marques, M, Ramirez, JL, Pineda, S, Dominguez-Rodriguez, S, Gago, JL, Badal, J, Carrato, C, Lopez, H, Quer, A, Castellano, D, Malats, N and Real, FX.
Immunohistochemistry-Based Taxonomical Classification of Bladder Cancer Predicts Response to Neoadjuvant Chemotherapy
Cancers 12(7):
-
Gonzalez-Cao, M, Moran, T, Dalmau, J, Garcia-Corbacho, J, Bracht, JWP, Bernabe, R, Juan, OS, de Castro, J, Blanco, R, Drozdowskyj, A, Argilaguet, J, Meyerhans, A, Blanco, J, Prado, JG, Carrillo, J, Clotet, B, Massuti, B, Provencio, M, Molina-Vila, MA, de las Casa, CM, Garzon, M, Cao, P, Huang, CY, Martinez-Picado, J and Rosell, R.
Assessment of the Feasibility and Safety of Durvalumab for Treatment of Solid Tumors in Patients With HIV-1 Infection The Phase 2 DURVAST Study
JAMA Oncology 6(7): 1063-1067
-
Mattesen TB, Rasmussen MH, Sandoval J, Ongen H, Árnadóttir SS, Gladov J, Martinez-Cardus A, de Moura MC, Madsen AH, Laurberg S, Dermitzakis ET, Esteller M, Andersen CL and Bramsen JB.
Publisher Correction: MethCORR modelling of methylomes from formalin-fixed paraffin-embedded tissue enables characterization and prognostication of colorectal cancer.
Nature Communications 11(1): 2880-2880
-
Powles T, Kockx M, Rodriguez-Vida A, Duran I, Crabb SJ, Van Der Heijden MS, Szabados B, Pous AF, Gravis G, Herranz UA, Protheroe A, Ravaud A, Maillet D, Mendez MJ, Suarez C, Linch M, Prendergast A, van Dam PJ, Stanoeva D, Daelemans S, Mariathasan S, Tea JS, Mousa K, Banchereau R and Castellano D.
Publisher Correction: Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial.
Nature Medicine 26(6): 983-983
-
Antelo G, Hierro C, Fernández JP, Baena E, Bugés C, Layos L, Manzano JL, Caro M and Mesia R.
Rectal neuroendocrine carcinoma: case report of a rare entity and perspective review of promising agents.
Drugs in Context 9:
-
Mattesen, TB, Rasmussen, MH, Sandoval, J, Ongen, H, Arnadottir, SS, Gladov, J, Martinez-Cardus, A, Castro de Moura, M, Madsen, AH, Laurberg, S, Dermitzakis, ET, Esteller, M, Andersen, CL and Bramsen, JB.
MethCORR modelling of methylomes from formalin-fixed paraffin-embedded tissue enables characterization and prognostication of colorectal cancer
Nature Communications 11(1): 2025-2025
-
Philip, PA, Lacy, J, Portales, F, Sobrero, A, Pazo-Cid, R, Mozo, JLM, Kim, EJ, Dowden, S, Zakari, A, Borg, C, Terrebonne, E, Rivera, F, Sastre, J, Bathini, V, Lopez-Trabada, D, Asselah, J, Saif, MW, Li, JS, Ong, TJ, Nydam, T and Hammel, P.
Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 study
Lancet Gastroenterology & Hepatology 5(3): 285-294
-
Panciroli, C, Lucente, G, Vidal, L, Carcereny, E, Quiroga, V, Pardo, JC, Romeo, M, Estival, A, Manzano, JL, Pardo, B, Velarde, JM, Esteve, AM, Lopez, D, Manes, A, Tuset, V, Villa, S and Quintero, CB.
Assessment of neurocognitive decline in cancer patients, except brain cancer, under long-term treatment with bevacizumab
CLINICAL & TRANSLATIONAL ONCOLOGY 22(3): 411-419
-
Castellvi, M, Felip, E, Ezeonwumelu, IJ, Badia, R, Garcia-Vidal, E, Pujantell, M, Gutierrez-Chamorro, L, Teruel, I, Martinez-Cardus, A, Clotet, B, Riveira-Munoz, E, Margeli, M and Ballana, E.
Pharmacological Modulation of SAMHD1 Activity by CDK4/6 Inhibitors Improves Anticancer Therapy
Cancers 12(3):
-
Capdevila, J, Arques, O, Mora, JRH, Matito, J, Caratu, G, Mancuso, FM, Landolfi, S, Barriuso, J, Jimenez-Fonseca, P, Lopez, CL, Garcia-Carbonero, R, Hernando, J, Matos, I, Paolo, N, Hernandez-Losa, J, Esteller, M, Martinez-Cardus, A, Tabernero, J, Vivancos, A and Palmer, HG.
Epigenetic EGFR Gene Repression Confers Sensitivity to Therapeutic BRAFV600E Blockade in Colon Neuroendocrine Carcinomas
Clinical Cancer Research 26(4): 902-909
-
Domine, M, Moran, T, Isla, D, Marti, JL, Sullivan, I, Provencio, M, Olmedo, ME, Ponce, S, Blasco, A and Cobo, M.
SEOM clinical guidelines for the treatment of small-cell lung cancer (SCLC) (2019)
CLINICAL & TRANSLATIONAL ONCOLOGY 22(2): 245-255
-
Pros, E, Saigi, M, Alameda, D, Gomez-Mariano, G, Martinez-Delgado, B, Alburquerque-Bejar, JJ, Carretero, J, Tonda, R, Esteve-Codina, A, Catala, I, Palmero, R, Jove, M, Lazaro, C, Patino-Garcia, A, Gil-Bazo, I, Verdura, S, Teule, A, Torres-Lanzas, J, Sidransky, D, Reguart, N, Pio, R, Juan-Vidal, O, Nadal, E, Felip, E, Montuenga, LM and Sanchez-Cespedes, M.
Genome-wide profiling of non-smoking-related lung cancer cells reveals common RB1 rearrangements associated with histopathologic transformation in EGFR-mutant tumors
Annals of Oncology 31(2): 274-282
-
Espana, S, de Oca, APM, Marques-Pamies, M, Cucurulll, M, Domenechl, M, Velarde, JM, Salinas, I, Moran, T and Etxaniz, O.
Endocrine adverse events related to immune-oncology agents: retrospective experience of a single institution
Translational Lung Cancer Research 9(1): 103-110
-
Gibert J, Clavé S, Hardy-Werbin M, Taus Á, Rocha P, Longarón R, Piquer G, Chaib I, Carcereny E, Morán T, Salido M, Dalmases A, Bellosillo B and Arriola E.
Concomitant genomic alterations in KRAS mutant advanced lung adenocarcinoma.
Lung Cancer 140: 42-45
-
Ruano-Ravina, A, Provencio, M, de Juan, VC, Carcereny, E, Moran, T, Rodriguez-Abreu, D, Lopez-Castro, R, Albite, EC, Guirado, M, Gonzalez, LG, Massuti, B, Granados, ALO, Blasco, A, Cobo, M, Garcia-Campelo, R, Bosch, J, Trigo, J, Juan, O, de la Rosa, CA, Domine, M, Sala, M, Oramas, J, Casal-Rubio, J and Cerezo, S.
Lung cancer symptoms at diagnosis: results of a nationwide registry study
ESMO Open 5(6):
-
Cirauqui, B, Moran, T, Estival, A, Quiroga, V, Etxaniz, O, Balana, C, Navarro, M, Villa, S, Ballester, R and Margeli, M.
Breast Cancer Patient with Li-Fraumeni Syndrome: A Case Report Highlighting the Importance of Multidisciplinary Management
Case Reports in Oncology 13(1): 130-138
-
Espana, S, de Olza, MO, Sala, N, Piulats, JM, Ferrandiz, U, Etxaniz, O, Heras, L, Buisan, O, Pardo, JC, Suarez, JF, Barretina, P, Comet, J, del Muro, XG, Sumoy, L and Font, A.
PSA Kinetics as Prognostic Markers of Overall Survival in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Abiraterone Acetate
Cancer Management and Research 12: 10251-10260
-
Barnadas, A, Munoz, M, Margeli, M, Chacon, JI, Cassinello, J, Antolin, S, Adrover, E, Ramos, M, Carrasco, E, Jimeno, MA, Ojeda, B, Gonzalez, X, Gonzalez, S, Constenla, M, Florian, J, Miguel, A, Llombart, A, Lluch, A, Ruiz-Borrego, M, Colomer, R and Del Barco, S.
BOMET-QoL-10 questionnaire for breast cancer patients with bone metastasis: the prospective MABOMET GEICAM study
Journal of Patient-Reported Outcomes 3(1): 72-72
-
Mesia, R, Bossi, P, Hansen, AR, Hsieh, CY, Licitra, LF, Tan, EH, Chen, P, Miller, J, Siu, LL and Haddad, RI.
Phase II study of CC-486 (oral azacitidine) in previously treated patients with locally advanced or metastatic nasopharyngeal carcinoma
European Journal of Cancer 123: 138-145
-
Blanch-Lombarte, O, Galvez, C, Revollo, B, Jimenez-Moyano, E, Llibre, JM, Manzano, JL, Boada, A, Dalmau, J, Speiser, DE, Clotet, B, Prado, JG and Martinez-Picado, J.
Enhancement of Antiviral CD8(+) T-Cell Responses and Complete Remission of Metastatic Melanoma in an HIV-1-Infected Subject Treated with Pembrolizumab
Journal of Clinical Medicine 8(12):
-
Perol, M, Pavlakis, N, Levchenko, E, Platania, M, Oliveira, J, Novello, S, Chiari, R, Moran, T, Mitry, E, Nuesch, E, Liu, T, Balas, B, Konopa, K and Peters, S.
Patient-reported outcomes from the randomized phase III ALEX study of alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer
Lung Cancer 138: 79-87
-
Conde, E, Hernandez, S, Martinez, R, Angulo, B, De Castro, J, Collazo-Lorduy, A, Jimenez, B, Muriel, A, Mate, JL, Moran, T, Aranda, I, Massuti, B, Rojo, F, Domine, M, Sansano, I, Garcia, F, Felip, E, Mancheno, N, Juan, O, Sanz, J, Gonzalez-Larriba, JL, Atienza-Cuevas, L, Arriola-Arellano, E, Abdulkader, I, Garcia-Gonzalez, J, Camacho, C, Rodriguez-Abreu, D, Teixido, C, Reguart, N, Gonzalez-Pineiro, A, Lazaro-Quintela, M, Lozano, MD, Gurpide, A, Gomez-Roman, J, Lopez-Brea, M, Pijuan, L, Salido, M, Arriola, E, Company, A, Insa, A, Esteban-Rodriguez, I, Saiz, M, Azkona, E, Alvarez, R, Artal, A, Plaza, ML, Aguiar, D, Enguita, AB, Benito, A, Paz-Ares, L, Garrido, P and Lopez-Rios, F.
Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Patients with Non-Small Cell Lung Carcinoma: the ROSING Study
Journal of Thoracic Oncology 14(12): 2120-2132
-
Powles, T, Kockx, M, Rodriguez-Vida, A, Duran, I, Crabb, SJ, Van der Heijden, MS, Szabados, B, Pous, AF, Gravis, G, Herranz, UA, Protheroe, A, Ravaud, A, Maillet, D, Mendez, MJ, Suarez, C, Linch, M, Prendergast, A, van Dam, PJ, Stanoeva, D, Daelemans, S, Mariathasan, S, Tea, JS, Mousa, K, Banchereau, R and Castellano, D.
Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial
Nature Medicine 25(11): 1706-1714
-
Benavides, M, Diaz-Rubio, E, Carrato, A, Abad, A, Guillen, C, Garcia-Alfonso, P, Gil, S, Cano, MT, Safont, MJ, Gravalos, C, Manzano, JL, Sanchez, A, Alcaide, J, Lopez, R, Massuti, B, Sastre, J, Martinez, E, Escudero, P, Mendez, M and Aranda, E.
Tumour location and efficacy of first-line EGFR inhibitors in KRAS/RAS wild-type metastatic colorectal cancer: retrospective analyses of two phase II randomised Spanish TTD trials
ESMO Open 4(6):
-
Marin-Aguilera, M, Reig, O, Mila-Guasch, M, Font, A, Domenech, M, Rodriguez-Vida, A, Carles, J, Suarez, C, del Alba, AG, Jimenez, N, Victoria, I, Sala-Gonzalez, N, Ribal, MJ, Lopez, S, Etxaniz, O, Anguera, G, Maroto, P, Fernandez, PL, Prat, A and Mellado, B.
The influence of treatment sequence in the prognostic value of TMPRSS2-ERG as biomarker of taxane resistance in castration-resistant prostate cancer
International Journal of Cancer 145(7): 1970-1981
-
de Porras, VR, Bystrup, S, Cabrero-de las Heras, S, Musulen, E, Palomero, L, Alonso, MH, Nieto, R, Arango, D, Moreno, V, Queralt, C, Manzano, JL, Layos, L, Buges, C and Martinez-Balibrea, E.
Tumor Expression of Cyclin-Dependent Kinase 5 (Cdk5) Is a Prognostic Biomarker and Predicts Outcome of Oxaliplatin-Treated Metastatic Colorectal Cancer Patients
Cancers 11(10):
-
Jayaram, A, Wingate, A, Wetterskog, D, Conteduca, V, Khalaf, D, Sharabiani, MTA, Calabro, F, Barwell, L, Feyerabend, S, Grande, E, Martinez-Carrasco, A, Font, A, Berruti, A, Sternberg, CN, Jones, R, Lefresne, F, Lahaye, M, Thomas, S, Joshi, S, Shen, D, Ricci, D, Gormley, M, Merseburger, AS, Tombal, B, Annala, M, Chi, KN, De Giorgi, U, Gonzalez-Billalabeitia, E, Wyatt, AW and Attard, G.
Plasma Androgen Receptor Copy Number Status at Emergence of Metastatic Castration-Resistant Prostate Cancer: A Pooled Multicohort Analysis
JCO Precision Oncology 3:
-
Hardy-Werbin, M, Quiroga, V, Cirauqui, B, Romeo, M, Felip, E, Teruel, I, Garcia, JJ, Erasun, C, Espana, S, Cucurull, M, Montprade, E, Pardo, JC, Carballo, D, Velarde, JM and Margeli, M.
Real-world data on T-DM1 efficacy - results of a single-center retrospective study of HER2-positive breast cancer patients
Scientific Reports 9(1): 12760-12760
-
Isla, D, De Las Penas, R, Insa, A, Marse, R, Martinez-Banaclocha, N, Mut, P, Moran, T, Sala, MA, Massuti, B, Ortega, AL, Jurado, JM, Gomez-Codina, J, Diz, P, Artal, A, Gutierrez, V, Vazquez, MF, Vinolas, N, Maestu, I, Camps, C, Alvarez, R, Soto, MAD, Ponce, S and Provencio, M.
Oral vinorelbine versus etoposide with cisplatin and chemo-radiation as treatment in patients with stage III non-small cell lung cancer: A randomized phase II (RENO study)
Lung Cancer 135: 161-168
-
Saigi, M, Alburquerque-Bejar, JJ and Sanchez-Cespedes, M.
Determinants of immunological evasion and immunocheckpoint inhibition response in non-small cell lung cancer: the genetic front
Oncogene 38(31): 5921-5932
-
Buckland, G, Travier, N, Arribas, L, del Barco, S, Pernas, S, Zamora, E, Bellet, M, Cirauqui, B, Margeli, M, Munoz, M, Tusquets, I, Arcusa, A, Javierre, C, Moreno, F, Valverde, Y, Jansen, E, Chajes, V, Castro, C and Agudo, A.
Changes in dietary intake, plasma carotenoids and erythrocyte membrane fatty acids in breast cancer survivors after a lifestyle intervention: results from a single-arm trial
Journal of Human Nutrition and Dietetics 32(4): 468-479
-
Garcia-Vidal, E, Badia, R, Pujantell, M, Castellvi, M, Felip, E, Clotet, B, Riveira-Munoz, E, Ballana, E and Este, JA.
Dual effect of the broad spectrum kinase inhibitor midostaurin in acute and latent HIV-1 infection
Antiviral Research 168: 18-27
-
Estival, A, Sanz, C, Ramirez, JL, Velarde, JM, Domenech, M, Carrato, C, de las Penas, R, Gil-Gil, M, Sepulveda, J, Armengol, R, Cardiel, I, Berrocal, A, Luque, R, Herrero, A and Balana, C.
Pyrosequencing versus methylation-specific PCR for assessment of MGMT methylation in tumor and blood samples of glioblastoma patients
Scientific Reports 9(1): 11125-11125
-
Garcia, YG, Ferre, AD, Mendiola, C, Barretina-Ginesta, MP, Garcia, LG, Bertran, AS, Barcelo, IB, Gil-Martin, M, Manzano, A, Perez, MJR, Marin, MR, Nunez, CA, Garcia-Martinez, E and Martin, AG.
Efficacy and safety results from GEICO 1205, a randomized phase II trial of neoadjuvant chemotherapy with or without bevacizumab for advanced epithelial ovarian cancer
International Journal of Gynecological Cancer 29(6): 1050-1056
-
Rodriguez, RM, Felip, E, Fabregas, MA, Dominguez, JR and Servio, LI.
Influence of systematic antibiotic prophylaxis and/or cystoscope cleaning/disinfecting method on urinary culture becoming positive after outpatient flexible cystoscopy
Archivos Espanoles de Urologia 72(6): 554-559
-
Castet, F, Brenes, J, Taberna, M and Mesia, R.
The emergence of long-term survivors in recurrent and metastatic squamous cell head and neck cancer
Current Opinion in Oncology 31(3): 160-168
-
Santos, C, Azuara, D, Vieitez, JM, Paez, D, Falco, E, Elez, E, Lopez-Lopez, C, Valladares, M, Robles-Diaz, L, Garcia-Alfonso, P, Buges, C, Duran, G, Salud, A, Navarro, V, Capella, G, Aranda, E, Salazar, R, de Mena, IR and Rodriguez, S.
Phase II study of high-sensitivity genotyping of KRAS, NRAS, BRAF and PIK3CA to ultra-select metastatic colorectal cancer patients for panitumumab plus FOLFIRI: the ULTRA trial
Annals of Oncology 30(5): 796-803
-
Morán T, Felip E, Bosch-Barrera J, de Aguirre I, Ramirez JL, Mesia C, Carcereny E, Roa D, Sais E, García Y, Blanco R, Sanchez S, Villacorta CR, Queralt C, Velarde JM and Rosell R.
Correction: Monitoring EGFR-T790M mutation in serum/plasma for prediction of response to third-generation EGFR inhibitors in patients with lung cancer.
Oncotarget 10(26): 2576-2576
-
Plaja, A, Berastegui, E, Nieto-Moragas, J, Sarrate, E, Gual-Capllonch, F, Quiroga, V and Sorigue, M.
Thromboembolism and bleeding in patients with cancer and mechanical heart valves
Journal of Thrombosis and Thrombolysis 47(3): 454-461
-
Vidal, J, Bellosillo, B, Vivas, CS, Garcia-Alfonso, P, Carrato, A, Cano, MT, Garcia-Carbonero, R, Elez, E, Losa, F, Massuti, B, Valladares-Ayerbes, M, Vieitez, JM, Manzano, JL, Azuara, D, Gallego, J, Pairet, S, Capella, G, Salazar, R, Tabernero, J, Aranda, E and Montagut, C.
Ultra-selection of metastatic colorectal cancer patients using next-generation sequencing to improve clinical efficacy of anti-EGFR therapy
Annals of Oncology 30(3): 439-446
-
Marin, M, Gudiol, C, Castet, F, Oliva, M, Peiro, I, Royo-Cebrecos, C, Carratala, J and Mesia, R.
Bloodstream infection in patients with head and neck cancer: a major challenge in the cetuximab era
CLINICAL & TRANSLATIONAL ONCOLOGY 21(2): 187-196
-
Font, A, Luque, R, Villa, JC, Domenech, M, Vazquez, S, Gallardo, E, Virizuela, JA, Beato, C, Morales-Barrera, R, Gelabert, A, Macia, S, Puente, J, Rubio, G, Maldonado, X, Perez-Valderrama, B, Pinto, A, Calvo, OF, Grande, E, Garde-Noguera, J, Fernandez-Parra, E and Arranz, JA.
The Challenge of Managing Bladder Cancer and Upper Tract Urothelial Carcinoma: A Review with Treatment Recommendations from the Spanish Oncology Genitourinary Group (SOGUG)
Targeted Oncology 14(1): 15-32
-
Oliva, M, Spreafico, A, Taberna, M, Alemany, L, Coburn, B, Mesia, R and Siu, LL.
Immune biomarkers of response to immune-checkpoint inhibitors in head and neck squamous cell carcinoma
Annals of Oncology 30(1): 57-67
-
Capdevila, J, Teule, A, Barriuso, J, Castellano, D, Lopez, C, Manzano, JL, Alonso, V, Garcia-Carbonero, R, Dotor, E, Matos, I, Custodio, A, Casanovas, O and Salazar, R.
Phase II Study of Everolimus and Octreotide LAR in Patients with Nonfunctioning Gastrointestinal Neuroendocrine Tumors: The GETNE1003_EVERLAR Study
Oncologist 24(1): 38-46
-
Moran, T, Quiroga, V, Cirauqui, B, Vila, L, Gil-Moreno, M, Carcereny, E, Margeli, M, AnaMunoz-Marmol, Mate, JL, Velarde, JM, Molina, MA and Rosell, R.
A Single-Center Retrospective Study of Patients with Double Primary Cancers: Breast Cancer and EGFR-Mutant Non-Small Cell Lung Cancer
Oncology Research and Treatment 42(3): 107-114